Malignant neoplasm of corpus uteri, including Hilmo

C3_CORPUS_UTERI_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule only females	313377
2. Check conditions None	313377
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C54 Hospital discharge: ICD-9 — 182 Hospital discharge: ICD-8 — 1820 Cause of death: ICD-10 — C54 Cause of death: ICD-9 — 182 Cause of death: ICD-8 — 1820 Cancer registry: Topography ICD-O-3 — C54 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	4144
4. Check minimum number of events None	4144
5. Include endpoints None	4144
6. Filter based on genotype QC (FinnGen only)	3772

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_CORPUS_UTERI_WIDE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	2
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C54
HD_ICD_9	182
HD_ICD_8	1820
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C54
COD_ICD_9	182
COD_ICD_8	1820
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C54
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of corpus uteri, including Hilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Malignant neoplasm of corpus uteri

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3772	3772	-
Unadjusted period prevalence (%)	1.34	1.34	-
Median age at first event (years)	65.60	65.60	-

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3880: Matched controls
38798

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JAL31

NOMESCO Finland

Laparoscopic omentectomy

119.2

314.7

160

C54.10

ICD-10 Finland

Malignant tumor of endometrium without histology

3069.3

309.3

295

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

307.7

2099

LCD01

NOMESCO Finland

Total laparoscopic hysterectomy

96.7

307.7

1423

231

LX1XE

NOMESCO Finland

Other gynecological ultrasound examination

17.6

307.7

786

553

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

28.5

307.7

261

A04AA02

ATC

granisetron; systemic, transdermal

209.0

307.7

308

JN4BD

NOMESCO Finland

Extensive body CT

13.5

307.7

860

800

C54.1

ICD-10 Finland

Malignant neoplasm: Endometrium

5251.9

307.7

474

WF002

NOMESCO Finland

Radical radiotherapy

70.7

307.7

270

H02AB02

ATC

dexamethasone; systemic

55.6

307.7

957

227

115

Kela drug reimbursment

Breast cancer

+∞

307.7

365

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

66.6

307.7

214

L02AB02

ATC

medroxyprogesterone; systemic

42.5

307.7

232

B01AB05

ATC

enoxaparin; parenteral

3.7

307.7

2059

9163

N95.0

ICD-10 Finland

Postmenopausal bleeding

10.3

307.7

1940

3431

LAF10

NOMESCO Finland

Bilateral salpingo-oophorectomy

9.6

307.7

676

832

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

4.5

307.7

2164

8528

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

5022.1

307.7

456

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

53.7

307.7

242

JN2DG

NOMESCO Finland

Very extensive MRI examination of lower part of abdoment with high intensity magnet

67.4

307.7

299

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

307.7

701

L02BG04

ATC

letrozole; oral

123.5

307.7

458

LCA06

NOMESCO Finland

Biopsy of endometrium

5.5

307.7

1415

3658

ZXC96

NOMESCO Finland

Robot assisted procedure

83.0

307.7

651

A03FA01

ATC

metoclopramide; systemic, rectal

5.6

307.7

1425

3660

L03AA13

ATC

pegfilgrastim; parenteral

4261.1

307.7

395

128

Kela drug reimbursment

Cancers of female genital organs

7289.3

307.7

1088

LCD00

NOMESCO Finland

Hysterectomy

7.0

307.7

753

1289

LCD04

NOMESCO Finland

Laparoscopic hysterectomy

10.1

307.7

755

903

XX3DW

NOMESCO Finland

Time consuming IT work

10.3

307.7

782

926

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

239.2

307.7

288

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

2512.5

307.7

666

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

307.7

853

XLD00

NOMESCO Finland

Sytologyspecimen from mouth of uterus

5.7

307.7

1222

2886

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

16.0

307.7

521

373

N85.1

ICD-10 Finland

Endometrial adenomatous hyperplasia

21.0

307.7

409

216

LAF11

NOMESCO Finland

Laparoscopic bilateral salpingo-oophorectomy

35.8

307.7

2140

1288

A04AA01

ATC

ondansetron; systemic, rectal

10.6

307.7

686

770

PJA12

NOMESCO Finland

Sentinel node biopsy

532.8

307.7

342

PJD63

NOMESCO Finland

Laparoscopic dissection of aortic lymph nodes

+∞

307.7

463

WF003

NOMESCO Finland

Adjuvant radiotherapy

1634.8

307.7

784

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

137.1

307.7

183

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

498.5

307.7

322

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

6.8

307.7

1227

2458

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

4503599627370496.0

307.7

3019

B01AB10

ATC

tinzaparin; parenteral

11.6

307.7

1487

1966

JN4AD

NOMESCO Finland

Body CT examination

10.3

307.7

956

1190

PJD54

NOMESCO Finland

Block dissection of iliac lymph nodes

1204.5

307.7

331

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

807.8

307.7

299

WX302

NOMESCO Finland

Thoracal epidural anesthesy

10.3

303.6

352

371

HAB40

NOMESCO Finland

Wedge excision of mammary gland

22.9

298.4

219

101

C54.9

ICD-10 Finland

Malignant neoplasm: Corpus uteri, unspecified

+∞

297.8

282

C54.14

ICD-10 Finland

Serous papillary carcinoma of the endometrium

+∞

294.6

279

JAL30

NOMESCO Finland

Omentectomy

28.2

289.2

196

LCA13

NOMESCO Finland

Curettage of cervix and body of uterus

4.5

280.3

819

2192

Z51.5

ICD-10 Finland

Palliative care

6.0

276.4

533

1000

C54.19

ICD-10 Finland

Malignant tumor of endometrium, unspecified histology

+∞

270.0

256

WZC00

NOMESCO Finland

Treatment plan or consultation

3.2

264.4

1770

8109

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

260.4

247

A04AA55

ATC

palonosetron, combinations; systemic

+∞

256.1

243

8380/2-C54.1

ICD-O-3

Endometrioid intraepithelial neoplasia of endometrium

43.6

253.1

151

D39.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Uterus

24.0

251.8

181

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

2419.4

248.4

238

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

246.5

234

WX402

NOMESCO Finland

General anaesthesia

3.4

243.1

1134

4156

130

Kela drug reimbursment

Malignant tumour

+∞

238.0

226

WF049

NOMESCO Finland

Radiotherapy of metastasis

816.8

237.1

231

ZX040

NOMESCO Finland

Intracavity HDR radiotherapy

+∞

235.9

224

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

7.8

234.4

340

472

N84.0

ICD-10 Finland

Polyp of corpus uteri

3.8

230.0

834

2584

D07.0

ICD-10 Finland

Carcinoma in situ: Endometrium

118.5

225.8

115

LEB00

NOMESCO Finland

Biopsy of vagina

8.7

222.0

290

355

ULC02

NOMESCO Finland

Hysteroscopy

4.7

219.5

574

1394

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

210.3

200

HA1AA

NOMESCO Finland

X-ray mammography

5.2

209.9

468

994

L02BA01

ATC

tamoxifen; oral

432.1

207.4

206

YL1AD

NOMESCO Finland

CT examination of pelvis for dose design of radiotherapy

+∞

207.2

197

TPH07

NOMESCO Finland

Cathetrisation of artery

3.9

202.3

693

2052

8441/3-C54.1

ICD-O-3

Serous carcinoma, NOS, of endometrium

+∞

201.8

192

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

197.6

188

WX404

NOMESCO Finland

Intravenous generell anesthesy

3.1

192.2

1023

3991

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

185.9

177

WW500

NOMESCO Finland

Blood transfusion

8.9

184.9

236

280

WF099

NOMESCO Finland

Other radiotherapy

57.0

177.5

100

1820A

ICD-9 Finland

Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[CARCINOMA ENDOMETRII]

+∞

174.3

166

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

173.2

165

JAP01

NOMESCO Finland

Laparoscopic freeing of adhesions in the peritoneal cavity

9.0

171.3

216

252

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

5.7

170.0

332

623

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

1662.4

160.5

155

JN4CD

NOMESCO Finland

Very extensive body CT

9.3

155.3

190

213

JN2DM

NOMESCO Finland

Lower part of abdomen very extensive MRI examination with Tesla magnet

66.0

152.9

HAC20

NOMESCO Finland

Total mastectomy

230.5

151.2

155

C54.12

ICD-10 Finland

Adenosquamous carcinoma of the endometrium

+∞

151.0

144

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

1495.7

146.8

142

WZC15, ,

NOMESCO Finland

63.6

146.5

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

258.1

146.3

149

LE090

NOMESCO Finland

Profylactive radiotherapy of vulva and vagina

+∞

145.7

139

D70.82

ICD-10 Finland

Drug-induced neutropenia

27.4

145.3

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

4.5

144.9

381

919

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

143.6

137

C50.99

ICD-10 Finland

Breast, unspecified

359.9

139.7

140

PJD53

NOMESCO Finland

Block dissection of aortic lymph nodes

+∞

138.4

132

N93.9

ICD-10 Finland

Abnormal uterine and vaginal bleeding, unspecified

6.8

136.7

221

343

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

1370.4

136.3

132

LCB25

NOMESCO Finland

Hysteroscopic excision of lesion

3.7

135.0

466

1369

C54.13

ICD-10 Finland

Clear cell carcinoma of the endometrium

+∞

134.1

128

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

452.9

132.9

132

L03AA02

ATC

filgrastim; parenteral

276.1

131.0

133

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

176.1

130.3

136

ZX090

NOMESCO Finland

Other technic of radiotherapy

225.9

127.6

131

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

29.2

124.5

Z08.9

ICD-10 Finland

Follow-up examination after unspecified treatment for malignant neoplasm

50.9

121.4

X77

ICPC

Malignant neopl genital female other

1205.0

120.5

117

JAL01

NOMESCO Finland

Laparoscopic biopsy of peritoneum

47.5

119.7

WF090

NOMESCO Finland

Profylactic radiotherapy

+∞

118.3

113

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

11.3

114.7

121

110

ZXE20

NOMESCO Finland

More than three and less than five hours

2.9

112.7

634

2486

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

111.0

106

Z31.5

ICD-10 Finland

Genetic counselling

5.0

110.0

244

510

C54

ICD-10 Finland

Malignant neoplasm of corpus uteri

1046.1

104.8

102

C54.21

ICD-10 Finland

Leiomyosarcoma and myometrium

+∞

104.6

100

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

273.1

104.4

106

JN2BG

NOMESCO Finland

MRI examination of lower part of abdoment with high intensity magnet

22.8

104.2

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

50.8

103.9

WF004

NOMESCO Finland

Palliative radiotherapy

353.2

103.7

104

JAL00

NOMESCO Finland

Biopsy of peritoneum

23.2

103.5

C54.23

ICD-10 Finland

Carcinosarcoma

+∞

102.5

C55

ICD-10 Finland

Malignant neoplasm of uterus, part unspecified

+∞

101.5

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

33.0

101.3

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

100.4

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

7.9

100.0

139

182

WZC30

NOMESCO Finland

Teaching

2.6

99.8

663

2818

C54.2

ICD-10 Finland

Malignant neoplasm: Myometrium

+∞

98.3

ZX070

NOMESCO Finland

Intensity modified radiotherapy

253.9

97.1

L01BC06

ATC

capecitabine; oral

+∞

96.2

XX2RW, ,

NOMESCO Finland

12.7

95.9

ZX120

NOMESCO Finland

Intravenous

3.3

95.5

400

1320

TLE20

NOMESCO Finland

Transvaginal puncture of cul-de-sac

31.5

95.2

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

2.7

95.0

592

2434

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.2

94.9

267

674

LCD30

NOMESCO Finland

Radical hysterectomy

198.9

93.8

ZX080

NOMESCO Finland

Image guided radiotherapy

474.0

93.7

LCA10

NOMESCO Finland

Curettage of body of uterus

4.4

93.1

242

575

C54.0

ICD-10 Finland

Malignant neoplasm: Isthmus uteri

+∞

93.1

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

+∞

91.0

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

8.8

90.1

114

133

N02AA05

ATC

oxycodone; systemic

2.2

87.2

888

4546

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

86.8

N85.0

ICD-10 Finland

Endometrial glandular hyperplasia

4.8

86.5

200

432

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

432.0

85.4

KH1BT

NOMESCO Finland

Urinary tract cathetrisation with X-ray guidance

14.2

85.3

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

846.6

84.9

TPX10

NOMESCO Finland

Implantation of vascular injection port

6.3

84.8

146

241

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

84.7

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

84.7

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

10.4

84.6

ZZR00

NOMESCO Finland

Flap of skin

15.1

83.7

C54.22

ICD-10 Finland

Endometrial stromal cell sarcoma

+∞

83.6

ZXE10

NOMESCO Finland

More than one and less than three hours

2.0

83.4

1526

9669

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

150.0

83.4

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

9.9

82.4

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

81.5

A79

ICPC

Malignancy NOS

112.5

81.2

Z51.0

ICD-10 Finland

Radiotherapy session

804.8

80.7

C50

ICD-10 Finland

Malignant neoplasm of breast

276.7

79.8

LC2HE

NOMESCO Finland

Hystero-salpingography with ultrasound

3.5

79.1

286

858

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

46.5

78.1

YX9VG

NOMESCO Finland

Other MRI eamination with high intensity magnet for dose design of radiotherapy

+∞

75.2

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

73.3

968

5430

L02BG03

ATC

anastrozole; oral

+∞

73.1

A04AD12

ATC

aprepitant; systemic

369.2

72.9

KBV02

NOMESCO Finland

Cystoscopic insertion of stent into ureter

6.4

72.8

123

199

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

71.0

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

71.0

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

690.4

69.2

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

69.0

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

8.9

67.4

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

65.8

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

648.9

65.1

8310/3-C54.1

ICD-O-3

Clear cell adenocarcinoma, NOS, of endometrium

+∞

64.8

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

64.8

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.6

64.3

417

1732

X76

ICPC

Malignant neoplasm breast female

138.4

64.1

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

3.3

63.9

258

828

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

63.7

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

317.0

62.6

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.4

60.9

477

2159

18200

ICD-8 Finland

Other malignant neoplasm of uterus, Carcinoma corporis uteri

+∞

60.6

8140/3-C54.1

ICD-O-3

Adenocarcinoma, NOS, of endometrium

+∞

60.6

B02AA02

ATC

tranexamic acid; systemic

2.0

59.9

729

3935

L02BG06

ATC

exemestane; oral

+∞

59.5

R19.0

ICD-10 Finland

Intra-abdominal and pelvic swelling, mass and lump

3.9

59.0

178

471

C54.29

ICD-10 Finland

Unspecified uterine sarcoma

+∞

58.5

ZXC40

NOMESCO Finland

Use of ultrasound

12.6

58.1

LAF16

NOMESCO Finland

Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer

154.9

58.0

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

4.8

56.8

129

274

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

56.4

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.4

56.0

206

623

WC125

NOMESCO Finland

Demanding cytostatic therapy of local tumor recidive

+∞

55.3

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

55.1

572

2902

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

545.6

54.7

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

7.6

53.0

100

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

12.9

52.9

C56.00

ICD-10 Finland

Malignant tumor of the ovary without histology

525.0

52.6

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

52.2

WC115

NOMESCO Finland

Cytostatic therapy of local tumor recidive with multiple drugs

+∞

52.2

8980/3-C54.1

ICD-O-3

Carcinosarcoma, NOS, of endometrium

+∞

52.2

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

16.5

52.2

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.5

52.0

184

543

JEA00

NOMESCO Finland

Appendectomy

3.0

51.9

243

849

X12

ICPC

Postmenopausal bleeding

5.9

51.9

163

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

51.1

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

504.4

50.5

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

50.1

1932

14544

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

10.1

49.6

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.3

49.2

422

1979

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

49.1

R93.5

ICD-10 Finland

Abnormal findings on diagnostic imaging of other abdominal regions, including retroperitoneum

4.1

49.0

137

343

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

483.8

48.5

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

248.0

48.1

C56.73

ICD-10 Finland

Endomeroid epithelial carcinoma of the ovary

+∞

48.0

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

48.0

HAB99

NOMESCO Finland

Other partial excision of mammary gland

5.7

47.5

156

JAH01

NOMESCO Finland

Laparoscopy

3.1

47.3

206

690

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.7

46.5

152

425

C56

ICD-10 Finland

Malignant neoplasm of ovary

237.8

46.1

E66.01

ICD-10 Finland

Obesity due to excess calories

2.3

45.8

396

1860

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

65.8

45.2

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

158.5

44.9

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

44.9

YL1CD

NOMESCO Finland

Very extensive CT examination of pelvis for dose design of radiotherapy

+∞

44.9

LC003

NOMESCO Finland

Adjuvant radiotherapy of uterus and uterine ligaments

+∞

44.9

R18

ICD-10 Finland

Ascites

5.8

44.7

144

N02BE01

ATC

paracetamol; systemic, rectal

2.5

44.4

3628

33077

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

10.8

43.5

NK6AN

NOMESCO Finland

Total body bone isotope imaging

12.9

43.5

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.8

43.0

227

846

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

116.4

42.8

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

42.8

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

14.1

42.5

8890/3-C54.9

ICD-O-3

Leiomyosarcoma, NOS, of corpus uteri

+∞

41.7

8890/3-C54.2

ICD-O-3

Leiomyosarcoma, NOS, of myometrium

+∞

41.7

KCD02

NOMESCO Finland

Transurethral resection of bladder

11.8

41.2

Y83.8

ICD-10 Finland

Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.6

40.7

138

396

KA1FN

NOMESCO Finland

Isotope renography

9.7

40.4

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

401.6

40.2

A04AA03

ATC

tropisetron; systemic

76.0

39.9

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

207.1

39.9

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

39.6

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

39.6

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

39.6

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

39.6

JA2AT

NOMESCO Finland

Abdominal puncture with ultrasound guidance

9.0

39.0

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

138.1

38.8

C50.00

ICD-10 Finland

Malignant tumor of nipple and areola, no histological veryfication

+∞

38.6

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.4

36.8

260

1117

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

36.5

C57.9

ICD-10 Finland

Malignant neoplasm: Female genital organ, unspecified

+∞

36.5

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

35.9

416

2181

JFF23

NOMESCO Finland

Transversostomy

10.6

35.8

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

35.5

B01AB04

ATC

dalteparin; parenteral

2.5

34.4

235

993

PJD43

NOMESCO Finland

Excision of aortic lymph nodes

+∞

34.4

C54.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of corpus uteri

+∞

34.4

JAH00

NOMESCO Finland

Laparotomy

3.5

34.0

118

344

Z85.4

ICD-10 Finland

Personal history of malignant neoplasm of genital organs

340.1

34.0

KBV15

NOMESCO Finland

Cystoscopic change of ureteral stent

13.4

34.0

8310

FHL

Radical hysterectomy (includes lymph node removal)

+∞

33.4

C53.02

ICD-10 Finland

Adenocarcinoma of the endocervix

+∞

33.4

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

5.4

33.2

125

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

74.8

32.9

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

32.3

C77.5

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes

+∞

32.3

A06AH03

ATC

naloxegol; oral

6.8

32.2

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

32.1

467

2638

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

319.6

31.9

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

4.0

31.7

224

ZX112

NOMESCO Finland

Subcutaneous

6.0

31.2

KBV12

NOMESCO Finland

Transluminal endoscopic removal of stent from ureter

5.3

30.6

116

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

30.2

L01EX08

ATC

lenvatinib; oral

+∞

30.2

3019

Kela drug reimbursment

Lenvatinib

+∞

30.2

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

30.2

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

30.2

1744A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-outer quadrant

+∞

30.2

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3.1

30.0

125

408

JFB00

NOMESCO Finland

Partial resection of small intestine

4.3

29.8

182

XX1AD

NOMESCO Finland

Other CT-examination

107.6

29.7

R50.9

ICD-10 Finland

Fever, unspecified

1.8

29.6

469

2718

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

29.5

518

3097

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

29.2

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

29.2

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

28.8

243

1125

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

294.1

28.8

G03DA02

ATC

medroxyprogesterone; systemic

1.7

28.7

601

3772

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

104.2

28.7

WPA10

NOMESCO Finland

Proactive palliative care treatment plan

10.8

28.7

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

28.2

C54.20

ICD-10 Finland

Malignant tumor of the myometrium without histology

+∞

28.2

G62.0

ICD-10 Finland

Drug-induced polyneuropathy

39.3

28.0

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

27.4

28.0

LCD31

NOMESCO Finland

Radical laparoscopic hysterectomy

146.1

27.7

ULA02

NOMESCO Finland

Kolposcopy

1.9

27.5

392

2197

C57.0

ICD-10 Finland

Malignant neoplasm: Fallopian tube

+∞

27.1

KH1FT

NOMESCO Finland

Exchange of urinary catheter with radiological guidance

24.0

27.0

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

41.5

26.8

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

272.9

26.7

ZXK00

NOMESCO Finland

Conversion from percutaneous endoscopic to open procedure

7.1

26.7

S18

ICPC

Laceration/cut

1.4

26.6

1762

14189

B03XA02

ATC

darbepoetin alfa; parenteral

4.3

26.5

164

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.4

26.3

181

767

1508

Kela drug reimbursment

Lenvatinib

+∞

26.1

C53.01

ICD-10 Finland

Squamous cell carcinoma of the endocervix

+∞

26.1

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

26.1

K62.7

ICD-10 Finland

Radiation proctitis

+∞

26.1

C53.11

ICD-10 Finland

Squamous cell carcinoma and exocervix

+∞

26.1

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

31.2

25.9

N81.2

ICD-10 Finland

Incomplete uterovaginal prolapse

0.3

25.8

2163

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

262.3

25.7

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

94.0

25.7

9707

FHL

Ablation of mammae and removal of axillary lymph nodes

135.9

25.6

Z3232

NOMESCO Finland

Midwife

2.6

25.3

150

593

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

50.4

25.2

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

4.2

25.2

162

B29

ICPC

Lymph/immune mech sympt/complt other

8.9

25.1

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

25.0

K52.0

ICD-10 Finland

Gastroenteritis and colitis due to radiation

58.4

25.0

XX1XN

NOMESCO Finland

Other isotope examination

251.8

24.7

YX9AW, ,

NOMESCO Finland

251.8

24.7

XW4AT

NOMESCO Finland

Biopsy of other inner organ with ultrasound guidance

43.1

24.6

JAL20

NOMESCO Finland

Excision or destruction of lesion of peritoneum

20.2

24.3

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

24.1

758

5239

X75

ICPC

Malignant neoplasm cervix

+∞

24.0

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

24.0

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

24.0

C50.29

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland, other or undeterminated histology

+∞

24.0

8380/3-C56.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of ovary

+∞

24.0

8931/3-C54.1

ICD-O-3

Endometrial stromal sarcoma, low grade of endometrium

+∞

24.0

N85.9

ICD-10 Finland

Noninflammatory disorder of uterus, unspecified

4.1

23.9

164

WX725

NOMESCO Finland

Noninvasive ventilation

2.2

23.8

207

970

WX704

NOMESCO Finland

Intubation

2.0

23.5

286

1519

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

6.8

23.3

JN2CM

NOMESCO Finland

Lower part of abdomen extensive MRI examination with Tesla magnet

33.6

23.3

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.8

23.2

115

415

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

3.8

23.0

187

XW3AT

NOMESCO Finland

Biopsy of other superficial organ with ultrasound guidance

9.1

23.0

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

22.9

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

22.9

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.3

22.8

275

K56.7

ICD-10 Finland

Ileus, unspecified

3.6

22.5

204

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

21.9

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

21.9

C56.98

ICD-10 Finland

Malignant tumor of the ovary, indeterminate histology

+∞

21.9

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

4.8

21.7

100

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

221.2

21.6

Z08.1

ICD-10 Finland

Follow-up examination after radiotherapy for malignant neoplasm

221.2

21.6

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

221.2

21.6

R2110

NOMESCO Finland

Giving the first information

1.9

21.5

277

1500

Z80.3

ICD-10 Finland

Family history of malignant neoplasm of breast

4.4

21.3

122

N81.1

ICD-10 Finland

Cystocele

0.5

21.2

159

3317

8306

FHL

Hysterectomy (related to abortion 8516, prolapse correction 8436)

0.1

21.2

1255

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

7.3

21.2

KBV00

NOMESCO Finland

Insertion of stent into ureter

7.1

20.8

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

5.5

20.7

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

110.6

20.6

G03AC03

ATC

levonorgestrel; oral, implant

0.5

20.4

162

3310

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

3.1

20.1

270

T81.2

ICD-10 Finland

Accidental puncture and laceration during a procedure, not elsewhere classified

3.6

20.1

191

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.8

20.0

102

374

LEF13

NOMESCO Finland

Colpoperineoplasty and vaginal hysterectomy

0.2

20.0

1253

8461/3-C56.9

ICD-O-3

High grade serous carcinoma of ovary

+∞

19.8

1XA02, ,

NOMESCO Finland

+∞

19.8

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

19.8

3AA13, ,

NOMESCO Finland

+∞

19.8

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

19.8

L02BA03

ATC

fulvestrant; parenteral

+∞

19.8

N95.1

ICD-10 Finland

Menopausal and female climacteric states

0.5

19.7

194

3684

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

19.4

970

7322

N02AX02

ATC

tramadol; systemic, rectal

1.4

19.3

1565

12812

JFB30

NOMESCO Finland

Right hemicolectomy

5.9

19.1

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

18.3

19.1

LFB00

NOMESCO Finland

Biopsy of vulva or perineum

2.3

19.0

150

677

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

18.8

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

18.8

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

18.8

159

Kela drug reimbursment

Pazopanib

+∞

18.8

YJ1AD

NOMESCO Finland

CT examination of abdomen for dose design of radiotherapy

+∞

18.8

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

+∞

18.8

8090/3-C44.1

ICD-O-3

Basal cell carcinoma, NOS, of eyelid

+∞

18.8

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

+∞

18.8

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

18.8

C78.2

ICD-10 Finland

Secondary malignant neoplasm of pleura

+∞

18.8

8323/3-C54.1

ICD-O-3

Mixed cell adenocarcinoma of endometrium

+∞

18.8

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

70.2

18.7

N30.4

ICD-10 Finland

Irradiation cystitis

70.2

18.7

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

7.7

18.7

PJA10

NOMESCO Finland

Exploration of lymph nodes

6.8

18.7

D39.10

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary without histology

2.5

18.7

121

500

ZYC01

NOMESCO Finland

Remote contact by phone

2.0

18.6

216

1128

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

190.9

18.5

Z70.8

ICD-10 Finland

Other sex counselling

14.2

18.5

JAD11

NOMESCO Finland

Laparoscopic repair of incisional hernia

3.5

18.5

187

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

16.2

18.3

XLD10

NOMESCO Finland

Gynaecological examination

5.0

18.3

GD1AD

NOMESCO Finland

Thorax CT examination

2.0

18.2

189

949

R4190

NOMESCO Finland

Nutritional therapy

2.7

18.2

370

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

14.4

18.1

2180A

ICD-9 Finland

Uterine leiomyoma, Submucous leiomyoma of uterus

0.4

18.0

105

2416

C20

ICD-10 Finland

Malignant neoplasm of rectum

+∞

17.7

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

17.7

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

+∞

17.7

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

17.7

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

17.7

N93.8

ICD-10 Finland

Other specified abnormal uterine and vaginal bleeding

2.9

17.7

286

Z3231

NOMESCO Finland

Registered nurse

1.4

17.4

896

6778

21899

ICD-8 Finland

Uterine fibroma

0.4

17.4

2049

TJF80

NOMESCO Finland

Ostomy education

6.0

17.3

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

42.2

17.3

LCA96

NOMESCO Finland

Other intrauterine operation

3.8

17.2

134

E66.9

ICD-10 Finland

Obesity, unspecified

2.2

16.8

142

659

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.9

16.8

267

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

16.7

C53.09

ICD-10 Finland

Malignant tumor of endocervix, unspecified histology

+∞

16.7

C50.22

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,lobular tumor

+∞

16.7

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

16.7

8461/3-C54.1

ICD-O-3

High grade serous carcinoma of endometrium

+∞

16.7

C79.2

ICD-10 Finland

Secondary malignant neoplasm of skin

+∞

16.7

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

16.7

8980/3-C54.9

ICD-O-3

Carcinosarcoma, NOS, of corpus uteri

+∞

16.7

ZX121

NOMESCO Finland

Central venous catheter

27.6

16.5

N84.1

ICD-10 Finland

Polyp of cervix uteri

2.2

16.5

145

684

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

16.3

292

1746

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.1

16.2

162

802

J01DB01

ATC

cefalexin; oral

1.4

16.2

2993

27451

E66.8

ICD-10 Finland

Other obesity

1.9

16.0

196

1044

LWA00

NOMESCO Finland

Repair of wound dehiscence in gynaecological surgery

13.6

16.0

A46

ICD-10 Finland

Erysipelas

1.5

15.9

532

3697

KA3EB

NOMESCO Finland

Antegrade pyelography

12.3

15.8

SPAT1153

SPAT

Removal of sutures

1.4

15.8

1111

8827

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.8

15.8

243

1391

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.7

15.8

138

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

12.9

15.6

8500/3-C50.1

ICD-O-3

Infiltrating duct carcinoma, NOS, of central portion of breast

+∞

15.6

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

15.6

L01CA04

ATC

vinorelbine; systemic

+∞

15.6

1CD02, ,

NOMESCO Finland

+∞

15.6

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

15.6

8930/3-C54.1

ICD-O-3

Endometrial stromal sarcoma, NOS, of endometrium

+∞

15.6

HAC25

NOMESCO Finland

Radical mastectomy

+∞

15.6

8070/3-C53.9

ICD-O-3

Squamous cell carcinoma, NOS, of cervix uteri

+∞

15.6

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

15.6

LDA20

NOMESCO Finland

Biopsy of vaginal cervix

1.9

15.5

200

1083

C50.82

ICD-10 Finland

Overall malignant tumor of the mammary gland, lobular tumor

160.6

15.5

N81.6

ICD-10 Finland

Rectocele

0.5

15.4

173

3165

UJF32

NOMESCO Finland

Coloscopy

1.4

15.4

999

7833

JN6AD

NOMESCO Finland

CT of torso and neck

4.9

15.2

R87.7

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal histological findings

5.3

15.1

TQW20

NOMESCO Finland

Tatoe

23.4

15.1

TQW99

NOMESCO Finland

Other minor procedure on skin

2.1

15.1

146

715

WX306

NOMESCO Finland

Lumbar epidural anesthesy

2.0

15.1

167

859

LCA98

NOMESCO Finland

Other transluminal endoscopic operation on uterus

3.6

15.1

133

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.7

14.9

296

1820

T90

ICPC

Diabetes non-insulin dependent

1.4

14.9

930

7239

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.0

14.8

163

836

LEE00

NOMESCO Finland

Suture of vagina

12.5

14.8

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

56.9

14.8

UKC02

NOMESCO Finland

Cystoscopy

1.5

14.7

421

2829

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

+∞

14.6

8461/3-C57.0

ICD-O-3

High grade serous carcinoma of fallopian tube

+∞

14.6

8520/3-C50.4

ICD-O-3

Lobular carcinoma, NOS, of upper-outer quadrant of breast

+∞

14.6

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

14.6

1830A

ICD-9 Finland

Malignant neoplasm of ovary and other uterine adnexa, Ovary

+∞

14.6

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

14.6

N85.7

ICD-10 Finland

Haematometra

6.3

14.5

TPX15

NOMESCO Finland

Removal of vascular injection port

14.2

14.5

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.9

14.4

183

986

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

14.4

2412

21571

A10BA02

ATC

metformin; oral

1.3

14.3

1053

8400

N93

ICD-10 Finland

Other abnormal uterine and vaginal bleeding

6.0

14.3

A08

ICPC

Swelling

1.7

14.3

273

1661

X81

ICPC

Genital neopl female other/unspecif

17.0

14.3

D75

ICPC

Malignant neoplasm colon/rectum

17.0

14.3

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

27.3

14.3

R07.4

ICD-10 Finland

Chest pain, unspecified

0.7

14.3

755

9754

R87.6

ICD-10 Finland

Abnormal findings in specimens from female genital organs, abnormal cytological findings

1.6

14.2

325

2070

KBV10

NOMESCO Finland

Removal of stent from ureter

5.1

14.1

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

6.7

14.0

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

5.7

13.7

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

13.6

258

1567

JGB03

NOMESCO Finland

Partial proctectomy with partial excision of mesorectum

75.4

13.6

8140/3-C53.9

ICD-O-3

Adenocarcinoma, NOS, of cervix uteri

+∞

13.5

C53.99

ICD-10 Finland

Malignant tumor in unspecified localization in cervix, unspecified histology

+∞

13.5

ZX020

NOMESCO Finland

HDR radiotherapy within tissue

+∞

13.5

WB133

NOMESCO Finland

Very demanding adjuvant cytostatic therapy

+∞

13.5

C90.0

ICD-10 Finland

Multiple myeloma

+∞

13.5

18220, ,

ICD-8 Finland

+∞

13.5

C50.19

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, other or undeterminated histology

+∞

13.5

192

Kela drug reimbursment

Fulvestrant

+∞

13.5

C77.1

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes

+∞

13.5

TPW99

NOMESCO Finland

Other minor surgical procedure on peripheral vessel or lymphatic system

4.1

13.5

JAA10

NOMESCO Finland

Excision of lesion of abdominal wall

25.8

13.4

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

4.6

13.3

Z93.3

ICD-10 Finland

Colostomy status

6.3

13.3

A40.8

ICD-10 Finland

Other streptococcal sepsis

4.1

13.3

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

2.6

13.2

286

Y60.0

ICD-10 Finland

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care during surgical operation

4.8

13.1

R31

ICD-10 Finland

Unspecified haematuria

1.7

12.9

235

1411

KH1YT

NOMESCO Finland

Percutaneous implantation of endoprothesis with radiological guidance

13.0

12.9

JFF10

NOMESCO Finland

Loop enterostomy

13.0

12.9

PJD45

NOMESCO Finland

Excision of inguinal lymph nodes

19.1

12.9

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

5.3

12.8

ZXD10

NOMESCO Finland

Scheduled procedure

1.3

12.7

1305

10879

L01XK02

ATC

niraparib; oral

+∞

12.5

C50.12

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,lobular tumor

+∞

12.5

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

12.5

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

12.5

L01CB01

ATC

etoposide; systemic

+∞

12.5

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

+∞

12.5

PJ5AQ

NOMESCO Finland

Sentinell lymphnode SPECT with low dose CT

+∞

12.5

L01AX03

ATC

temozolomide; systemic

+∞

12.5

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

12.5

C50.10

ICD-10 Finland

Malignant tumor of the central part of the mammary gland, no histological veryfication

+∞

12.5

1CD01, ,

NOMESCO Finland

+∞

12.5

HA1SA

NOMESCO Finland

Expansion mammography

17.4

12.5

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.3

12.3

881

6978

C03CA01

ATC

furosemide; systemic

1.3

12.2

1322

11080

JN3KE

NOMESCO Finland

Abdominal ultrasound with added contrast

12.4

12.1

5703

FHL

Removal of lymph nodes from the retroperitoneal space

26.8

12.0

D25.9

ICD-10 Finland

Leiomyoma of uterus, unspecified

1.5

11.9

387

2668

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.3

11.9

931

7461

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.6

11.9

272

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

0.7

11.8

416

5792

U06

ICPC

Haematuria

2.4

11.8

321

A41.9

ICD-10 Finland

Sepsis, unspecified

2.1

11.7

115

567

A02BC02

ATC

pantoprazole; systemic

1.3

11.7

2614

23904

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.4

11.7

494

3584

KAC10

NOMESCO Finland

Total nephrectomy with capsule

12.6

11.6

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

12.6

11.6

C44.10

ICD-10 Finland

Malignant tumor of the skin of the eyelids including the corner of the eye without histology

65.1

11.6

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

22.9

11.6

JG1BG

NOMESCO Finland

MRI of rectum

22.9

11.6

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

3.5

11.5

113

HA1HA

NOMESCO Finland

Tomosynthesis mammography

11.1

11.5

X14

ICPC

Vaginal discharge

2.6

11.5

259

LEF00

NOMESCO Finland

Anterior colporraphy with sutures for primary cystocele

0.5

11.5

1719

SPAT1125

SPAT

Stoma care and guidance

2.4

11.5

313

C80.92

ICD-10 Finland

Malignant tumor without specified localization adenocarcinoma

+∞

11.5

PJW99

NOMESCO Finland

Other operation on lymphatic system

+∞

11.5

1510

Kela drug reimbursment

Niraparib

+∞

11.5

C50.92

ICD-10 Finland

Malignant tumor in another specified localization in lobular gland, lobular tumor

+∞

11.5

343

Kela drug reimbursment

Pazopanib

+∞

11.5

3009

Kela drug reimbursment

Niraparib

+∞

11.5

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

+∞

11.5

8010/3-C54.1

ICD-O-3

Carcinoma, NOS, of endometrium

+∞

11.5

8070/3-C44.3

ICD-O-3

Squamous cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

11.5

8441/3-C56.9

ICD-O-3

Serous carcinoma, NOS, of ovary

+∞

11.5

1501

Kela drug reimbursment

Palbociclib

+∞

11.5

8980/3-C54.2

ICD-O-3

Carcinosarcoma, NOS, of myometrium

+∞

11.5

8090/3-C44.4

ICD-O-3

Basal cell carcinoma, NOS, of skin of scalp and neck

+∞

11.5

394

Kela drug reimbursment

Palbociclib

+∞

11.5

KH1CD

NOMESCO Finland

Very extensive urinary tract ultrasound examination

4.0

11.5

P01AB01

ATC

metronidazole; oral, rectal

1.3

11.4

1502

12868

KH1AA

NOMESCO Finland

Urinary tract X-ray examination without contrast

3.6

11.4

104

C53

ICD-10 Finland

Malignant neoplasm of cervix uteri

120.4

11.4

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

120.4

11.4

D39.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Female genital organ, unspecified

4.8

11.4

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.8

11.4

169

958

K43.2

ICD-10 Finland

Incisional hernia without obstruction or gangrene

4.1

11.4

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

3.3

11.3

129

ZX050

NOMESCO Finland

Stereotactic radiotherapy

11.8

11.3

103

Kela drug reimbursment

Diabetes, insulin-treated

1.3

11.3

968

7848

L57.0

ICD-10 Finland

Actinic keratosis

1.5

11.3

374

2590

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

10.5

11.2

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

10.5

11.2

E66.00

ICD-10 Finland

Metabolic syndrome

1.7

11.2

186

1089

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

11.2

3223

30387

LAE21

NOMESCO Finland

Bilateral laparoscopic oophorectomy

4.6

11.2

8305

FHL

Supravaginal amputation or resection

0.2

11.2

682

D45

ICD-10 Finland

Polycythaemia vera

20.1

11.1

I80.1

ICD-10 Finland

Phlebitis and thrombophlebitis of femoral vein

2.8

11.1

189

WX400

NOMESCO Finland

Inhalation anesthesy

2.0

11.0

123

637

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

43.4

10.9

ZSH00

NOMESCO Finland

Procedure related to previous procedure classified in chapter H

43.4

10.9

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.4

10.9

302

R03DC03

ATC

montelukast; oral

0.7

10.8

341

4857

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.7

10.7

184

1089

SPAT1088

SPAT

Blood transfusion

4.7

10.7

NK6BQ

NOMESCO Finland

Whole body extensive bone SPET with low dose CT

21.5

10.7

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

21.5

10.7

HWD00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of mammary gland

8.5

10.5

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

9.2

10.5

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.7

10.5

196

1187

G02BA03

ATC

plastic IUD with progestogen

0.5

10.5

1769

A10BJ06

ATC

semaglutide; parenteral

1.8

10.4

168

976

C44.01

ICD-10 Finland

Basocellular carcinoma of the lip skin

110.3

10.4

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

110.3

10.4

C64

ICD-10 Finland

Malignant neoplasm of kidney, except renal pelvis

110.3

10.4

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

110.3

10.4

CBB50

NOMESCO Finland

Excision of lesion of eyelid and reconstruction using graft or flap

110.3

10.4

C56.72

ICD-10 Finland

Mucinous epithelial carcinoma of the ovary

+∞

10.4

8140/3-C54.9

ICD-O-3

Adenocarcinoma, NOS, of corpus uteri

+∞

10.4

C50.5

ICD-10 Finland

Malignant neoplasm: Lower-outer quadrant of breast

+∞

10.4

C48.89

ICD-10 Finland

Overall malignant tumor of the peritoneum and retroperitoneum other or unspecified tumor

+∞

10.4

C56.79

ICD-10 Finland

Other epithelial carcinoma of the ovary

+∞

10.4

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

10.4

C77.4

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes

+∞

10.4

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

10.4

8480/3-C50.9

ICD-O-3

Mucinous adenocarcinoma of breast, NOS

+∞

10.4

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

+∞

10.4

L01XE11

ATC

[U] pazopanib

+∞

10.4

8310/3-C56.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of ovary

+∞

10.4

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

10.4

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

10.4

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

10.4

C50.39

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, other or undeterminated histology

+∞

10.4

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

+∞

10.4

8090/3-C44.6

ICD-O-3

Basal cell carcinoma, NOS, of skin of upper limb and shoulder

+∞

10.4

C80.99

ICD-10 Finland

Malignant tumor without specified localization or histology

+∞

10.4

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

10.4

1820C

ICD-9 Finland

Malignant neoplasm of body of uterus, Corpus uteri, except isthmus[SARCOMA MYOMETRI]

+∞

10.4

N71.1

ICD-10 Finland

Chronic inflammatory disease of uterus

5.4

10.4

LCD97

NOMESCO Finland

Other laparoscopic hysterectomy

7.7

10.4

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

2.7

10.3

208

PJ1AN

NOMESCO Finland

Lymphsystem isotope imaging

32.6

10.3

S77

ICPC

Malignant neoplasm of skin

10.6

10.3

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.0

10.2

143

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.3

10.2

312

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

2.8

10.1

182

DHB00

NOMESCO Finland

Excision of lesion of external nose

7.9

10.1

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

11.3

10.0

JG1CG

NOMESCO Finland

Extensive MRI of rectum

11.3

10.0

TQB05

NOMESCO Finland

Puncture of skin of trunk

10.0

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

10.0

254

1661

XW2AT

NOMESCO Finland

Cytology of deep organ with ultrasound quidance

40.2

10.0

HWH99

NOMESCO Finland

Other reoperation in surgery of mammary gland

16.7

9.9

LWF00

NOMESCO Finland

Reoperation for insufficiency of anastomosis or suture in gynaecological surgery

12.2

9.8

8308

FHL

Hysterectomy and bilateral adnexal removal

1.9

9.8

127

691

Y83.6

ICD-10 Finland

Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

8.1

9.8

Z08.8

ICD-10 Finland

Follow-up examination after other treatment for malignant neoplasm

26.1

9.8

M05BA02

ATC

clodronic acid; systemic

20.1

9.8

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

9.5

9.7

J01CE08

ATC

benzathine benzylpenicillin; parenteral

2.9

9.6

148

D39.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other female genital organs

7.8

9.6

LEF03

NOMESCO Finland

Posterior colporrpahy with sutures for primary rectocele

0.5

9.6

1729

C10AX09

ATC

ezetimibe; oral

0.7

9.5

370

5080

GA4AT

NOMESCO Finland

Cathetrisation of pleural cavity with ultrasound guidance

3.2

9.4

113

C51.11

ICD-10 Finland

Squamous cell carcinoma of the labium minus

100.3

9.4

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

100.3

9.4

KKA10

NOMESCO Finland

Biopsy of retroperitoneal tissue

100.3

9.4

C82.1

ICD-10 Finland

Follicular lymphoma grade II

100.3

9.4

C53.12

ICD-10 Finland

Adenocarcinoma of the exocervix

100.3

9.4

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

30.1

9.4

WD315

NOMESCO Finland

Multiple therapy of methastized malignancy with biomodifiers

30.1

9.4

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

2.2

9.4

375

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

+∞

9.4

C50.1

ICD-10 Finland

Malignant neoplasm: Central portion of breast

+∞

9.4

8020/3-C54.1

ICD-O-3

Carcinoma, undifferentiated, NOS, of endometrium

+∞

9.4

C18.19

ICD-10 Finland

Malignant tumor in appendix other or unspecified histology

+∞

9.4

1800A

ICD-9 Finland

Malignant neoplasm of cervix uteri, Endocervix

+∞

9.4

18221, ,

ICD-8 Finland

+∞

9.4

YJ1BD

NOMESCO Finland

Extensive CT examination of abdomen for dose design of radiotherapy

+∞

9.4

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

9.4

8500/3-C50.3

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-inner quadrant of breast

+∞

9.4

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

+∞

9.4

8140/3-C34.1

ICD-O-3

Adenocarcinoma, NOS, of upper lobe, lung

+∞

9.4

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

9.4

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

9.4

YX9CD

NOMESCO Finland

Other very extensive CT eamination for dose design of radiotherapy

+∞

9.4

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

+∞

9.4

C78.5

ICD-10 Finland

Secondary malignant neoplasm of large intestine and rectum

+∞

9.4

C78.8

ICD-10 Finland

Secondary malignant neoplasm of other and unspecified digestive organs

+∞

9.4

K65.0

ICD-10 Finland

Acute peritonitis

3.1

9.3

124

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

9.3

1051

8792

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

4.5

9.3

N82.0

ICD-10 Finland

Vesicovaginal fistula

13.7

9.2

G03DB01

ATC

dydrogesterone; oral

1.4

9.1

484

3648

LCD11

NOMESCO Finland

Laparoscopically assisted vaginal hysterectomy

2.2

9.1

322

LEC00

NOMESCO Finland

Partial excision of vagina

15.6

9.0

OAA41

NOMESCO Finland

Health check based on individual needs

36.8

9.0

I89.8

ICD-10 Finland

Other specified noninfective disorders of lymphatic vessels and lymph nodes

36.8

9.0

J45

ICD-10 Finland

Asthma

0.6

9.0

195

3006

WX234

NOMESCO Finland

Paracervical blockade

2.7

9.0

171

SPAT1262

SPAT

Handing over of treatment supplies

1.3

9.0

578

4486

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

8.9

210

1349

QX3AT

NOMESCO Finland

Ultrasound guided biopsy of subcutaneous tissue

7.4

8.9

JFB46

NOMESCO Finland

Resection of sigmoid colon

3.0

8.9

128

KH1BD

NOMESCO Finland

Extensive urinary tract CT examination

3.9

8.9

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.6

8.8

184

Z80.4

ICD-10 Finland

Family history of malignant neoplasm of genital organs

6.8

8.8

L01XX05

ATC

hydroxycarbamide; oral

10.7

8.8

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

8.8

254

1710

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

2.3

8.7

295

C43.79

ICD-10 Finland

Malignant melanoma of the lower extremity including hip or other unspecified histology

50.1

8.7

M04AA01

ATC

allopurinol; systemic

1.4

8.7

332

2364

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

4.4

8.6

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.4

8.6

466

3521

WPA13

NOMESCO Finland

Palliative consultation

4.8

8.6

A40.1

ICD-10 Finland

Sepsis due to streptococcus, group B

9.0

8.5

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

0.6

8.5

164

2598

D77

ICPC

Malignant digestive neopl other/NOS

27.6

8.5

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

27.6

8.5

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.3

8.5

280

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

90.3

8.4

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

90.3

8.4

JN7AQ

NOMESCO Finland

Somatostatin receptor SPET med low dose CT

90.3

8.4

C53.00

ICD-10 Finland

Malignant tumor of endocervix without histology

90.3

8.4

FM1FN

NOMESCO Finland

Heart function isotope examination

90.3

8.4

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

4.9

8.4

6170A

ICD-9 Finland

Endometriosis of uterus

0.2

8.3

362

8931/3-C54.2

ICD-O-3

Endometrial stromal sarcoma, low grade of myometrium

+∞

8.3

C78.1

ICD-10 Finland

Secondary malignant neoplasm of mediastinum

+∞

8.3

C56.92

ICD-10 Finland

Malignant ovarian tumor, sex chord stroma derived

+∞

8.3

8070/3-C51.9

ICD-O-3

Squamous cell carcinoma, NOS, of vulva, NOS

+∞

8.3

C21.1

ICD-10 Finland

Malignant neoplasm: Anal canal

+∞

8.3

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

8.3

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

+∞

8.3

C77.3

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Axillary and upper limb lymph nodes

+∞

8.3

C57.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of female genital organs

+∞

8.3

L01EF01

ATC

palbociclib; oral

+∞

8.3

C34.19

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology

+∞

8.3

WB402

NOMESCO Finland

Demanding antibody therapy of primary tumour

+∞

8.3

JAQ00

NOMESCO Finland

Extensive excision of peritoneum

+∞

8.3

8522/3-C50.9

ICD-O-3

Infiltrating duct and lobular carcinoma of breast, NOS

+∞

8.3

LFD10

NOMESCO Finland

Vulvectomy and excision of regional lymph nodes

+∞

8.3

1745A

ICD-9 Finland

Malignant neoplasm of female breast, Lower-outer quadrant

+∞

8.3

C50.32

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, lobular tumor

+∞

8.3

N13.1

ICD-10 Finland

Hydronephrosis with ureteral stricture, not elsewhere classified

8.5

8.3

HAE99

NOMESCO Finland

Other reconstruction of breast

10.8

8.3

J45.1

ICD-10 Finland

Nonallergic asthma

0.6

8.2

114

1964

KBJ10

NOMESCO Finland

Cutaneous ureteroenterostomy

14.5

8.2

TJA10

NOMESCO Finland

Laparocentesis

14.5

8.2

N63

ICD-10 Finland

Unspecified lump in breast

1.6

8.2

201

1305

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.4

8.1

359

2623

KAC11

NOMESCO Finland

Total nephrectomy with capsule, transcutaneous

17.2

8.1

R60.0

ICD-10 Finland

Localized oedema

1.3

8.0

523

4063

R03BA01

ATC

beclometasone; inhalant

0.7

7.9

308

4236

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

7.2

7.9

ZXH04

NOMESCO Finland

Procedure performed in other inpatient unit

4.3

7.9

N99.4

ICD-10 Finland

Postprocedural pelvic peritoneal adhesions

2.7

7.9

154

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

4.6

7.9

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

7.8

7.9

6271A

ICD-9 Finland

Menopausal and postmenopausal disorders, Postmenopausal bleeding

2.0

7.8

396

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

2.9

7.8

116

JFA80

NOMESCO Finland

Suture of colon

10.8

7.8

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

0.8

7.8

679

8298

6500B

ICD-9 Finland

Delivery in a completely normal case[PARTUS SINE COMPLICATIONE]

0.7

7.7

345

4635

QWA00

NOMESCO Finland

Repair of wound dehiscence in surgery of skin

4.2

7.7

C44.3

ICD-10 Finland

Malignant neoplasm: Skin of other and unspecified parts of face

45.1

7.7

R03BB04

ATC

tiotropium bromide; inhalant

0.6

7.7

139

2234

UKB02

NOMESCO Finland

Retrograde ureteroscopy

3.4

7.7

R03AC02

ATC

salbutamol; inhalant

0.8

7.6

1627

18091

ZX100

NOMESCO Finland

Oral

2.7

7.6

140

J01MA12

ATC

levofloxacin; systemic

1.3

7.6

532

4175

A21

ICPC

Risk factor for malignancy

25.0

7.6

LEB10

NOMESCO Finland

Excision of lesion of vagina

3.5

7.5

JFB60

NOMESCO Finland

Resection of sigmoid colon with end colostomy

3.8

7.5

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

80.2

7.4

JFA70

NOMESCO Finland

Suture of small intestine

6.5

7.4

M25.5

ICD-10 Finland

Pain in joint

0.8

7.4

889

10480

BA3AT

NOMESCO Finland

Cytology of thyroid with ultrasound quidance

2.3

7.4

245

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.7

7.4

118

687

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

7.4

529

4165

LDA10

NOMESCO Finland

Curettage of cervix uteri

1.7

7.3

133

802

LDA00

NOMESCO Finland

Dilatation of cervix uteri

2.8

7.3

126

C18.99

ICD-10 Finland

Malignant tumor in unspecified location in the colon other or unspecified histology

+∞

7.3

C26.0

ICD-10 Finland

Malignant neoplasm: Intestinal tract, part unspecified

+∞

7.3

C18.7

ICD-10 Finland

Malignant neoplasm: Sigmoid colon

+∞

7.3

18202

ICD-8 Finland

Other malignant neoplasm of uterus, Sarcoma uteri

+∞

7.3

1514, ,

Kela drug reimbursment

+∞

7.3

C54.3

ICD-10 Finland

Malignant neoplasm: Fundus uteri

+∞

7.3

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

7.3

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

+∞

7.3

C18.11

ICD-10 Finland

Malignant tumor of the appendix invasive carcinoma

+∞

7.3

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

7.3

C18.30

ICD-10 Finland

Malignant tumor of flexura hepatica without histology

+∞

7.3

C44.81

ICD-10 Finland

Overall basocellular carcinoma of the skin

+∞

7.3

9950/3-C42.1

ICD-O-3

Polycythemia vera of bone marrow

+∞

7.3

C56.74

ICD-10 Finland

Mesonephroid epithelial carcinoma of the ovary

+∞

7.3

WC205

NOMESCO Finland

Simple therapy of local tumor recidive with hormone

+∞

7.3

C53.0

ICD-10 Finland

Malignant neoplasm: Endocervix

+∞

7.3

C79.1

ICD-10 Finland

Secondary malignant neoplasm of bladder and other and unspecified urinary organs

+∞

7.3

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

7.3

8620/3-C56.9

ICD-O-3

Adult granulosa cell tumor of ovary of ovary

+∞

7.3

8000/3-C54.9

ICD-O-3

Neoplasm, malignant of corpus uteri

+∞

7.3

C56.91

ICD-10 Finland

Malignant granulosa cell tumor in ovary

+∞

7.3

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

7.3

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

+∞

7.3

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

+∞

7.3

18201

ICD-8 Finland

Other malignant neoplasm of uterus, Carcinoma corporis et cervicis uteri

+∞

7.3

D05.0

ICD-10 Finland

Lobular carcinoma in situ

+∞

7.3

C43.70

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip without histology

+∞

7.3

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

7.3

3002

Kela drug reimbursment

Ribociclib

+∞

7.3

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

+∞

7.3

1XC07, ,

NOMESCO Finland

+∞

7.3

C10AA07

ATC

rosuvastatin; oral

0.8

7.3

1011

11740

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.5

7.2

1404

I80.8

ICD-10 Finland

Phlebitis and thrombophlebitis of other sites

2.4

7.2

191

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

0.8

7.2

726

8738

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.8

7.2

109

624

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

15.8

7.2

KCD10

NOMESCO Finland

Partial cystectomy

30.1

7.1

XX9AN

NOMESCO Finland

Complementary isotope examination or additional picture

30.1

7.1

WPA16

NOMESCO Finland

Extensive demanding palliative symptom assessment and treatment

20.0

7.1

NK6AQ

NOMESCO Finland

Whole body bone SPET with low dose CT

20.0

7.1

Z2221

NOMESCO Finland

Medical doctor

1.2

7.1

836

6994

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

2.8

7.1

128

KBH20

NOMESCO Finland

Replantation of ureter

7.9

7.1

Y69

ICD-10 Finland

Unspecified misadventure during surgical and medical care

2.5

7.1

175

SPAT1229

SPAT

Assessment of need for aid

1.4

7.1

334

2468

KCW02

NOMESCO Finland

Lavation of bladder for coagulated blood

8.8

7.0

K83.1

ICD-10 Finland

Obstruction of bile duct

2.7

7.0

129

J45.9

ICD-10 Finland

Asthma, unspecified

0.8

7.0

492

6190

HA1BG

NOMESCO Finland

MRI examination of mammary gland with high intensity magnet

7.0

J94.8

ICD-10 Finland

Other specified pleural conditions

2.6

7.0

141

M03BX02

ATC

tizanidine; oral

0.8

6.9

1793

19667

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

2.8

6.9

113

JAD10

NOMESCO Finland

Repair of incisional hernia

3.0

6.9

T88.9

ICD-10 Finland

Complication of surgical and medical care, unspecified

3.7

6.9

SPAT1255

SPAT

Intravenous administration of medicine

1.5

6.9

205

1390

L04AX03

ATC

methotrexate; systemic

0.7

6.9

188

2759

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.2

6.9

240

GA1AE

NOMESCO Finland

Ultrasound examination of thorax

2.3

6.8

228

Z80.8

ICD-10 Finland

Family history of malignant neoplasm of other organs or systems

8.3

6.8

GDB11

NOMESCO Finland

Thoracoscopic wedge resection of lung

6.1

6.8

XW4CT

NOMESCO Finland

Biopsy of other inner organ with CT guidance

40.1

6.8

OAB39

NOMESCO Finland

Sexual health guidance

40.1

6.8

JGB30

NOMESCO Finland

Abdominoperineal excision of rectum

40.1

6.8

R01AD09

ATC

mometasone; nasal

0.8

6.7

1197

13598

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

3.6

6.7

JLC30

NOMESCO Finland

Pancreatoduodenectomy

16.7

6.7

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

0.8

6.7

510

6357

LCD10

NOMESCO Finland

Vaginal hysterectomy

0.5

6.7

1057

LAE20

NOMESCO Finland

Bilateral oophorectomy

3.1

6.7

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

22.5

6.7

D05.9

ICD-10 Finland

Carcinoma in situ of breast, unspecified

22.5

6.7

TQW40, ,

SPAT

1.4

6.7

297

2174

Z30.1

ICD-10 Finland

Insertion of (intrauterine) contraceptive device

0.4

6.6

762

N05CB02

ATC

barbiturates in combination with other drugs

1.6

6.6

134

832

N06DA02

ATC

donepezil; oral

0.7

6.6

166

2480

LCB98

NOMESCO Finland

Other transluminal endoscopic excision of lesion of uterus

2.6

6.6

139

E14.9

ICD-10 Finland

Unspecified diabetes mellitus, without complications

2.2

6.6

251

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

2.4

6.6

169

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

2.1

6.5

285

R96

ICPC

Asthma

0.7

6.5

235

3273

O80.0

ICD-10 Finland

Spontaneous vertex delivery

0.6

6.5

148

2254

XX9AQ

NOMESCO Finland

Supplementary SPECT-CT or additional scan

70.0

6.4

WPA16, ,

SPAT

70.0

6.4

YN7AD

NOMESCO Finland

CT examination of spine for dose design of radiotherapy

70.0

6.4

JA2CT

NOMESCO Finland

Abdominal puncture with CT guidance

70.0

6.4

Y60.8

ICD-10 Finland

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care during other surgical and medical care

7.4

6.4

M01AB05

ATC

diclofenac; systemic, rectal

0.8

6.4

2005

21699

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

2.0

6.4

356

D39.19

ICD-10 Finland

Tumor of uncertain or unknown nature in the ovary with unspecified histology

3.0

6.4

ZYC05

NOMESCO Finland

Non-real-time text-based remote communication

2.3

6.3

197

R03AK07

ATC

formoterol and budesonide; inhalant

0.8

6.3

434

5483

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.0

6.3

309

K56.0

ICD-10 Finland

Paralytic ileus

2.9

6.3

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.6

6.3

128

797

GDC00

NOMESCO Finland

Lobectomy of lung

18.0

6.3

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

18.0

6.3

G03FB06

ATC

medroxyprogesterone and estrogen; systemic

1.3

6.3

545

4398

C66

ICD-10 Finland

Malignant neoplasm of ureter

+∞

6.2

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

+∞

6.2

KBD00

NOMESCO Finland

Partial excision of ureter

+∞

6.2

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

6.2

D05.7

ICD-10 Finland

Other carcinoma in situ of breast

+∞

6.2

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

+∞

6.2

C18

ICD-10 Finland

Malignant neoplasm of colon

+∞

6.2

YN7BD

NOMESCO Finland

Extensive CT examination of spine for dose design of radiotherapy

+∞

6.2

L01EF02

ATC

ribociclib; oral

+∞

6.2

C50.01

ICD-10 Finland

Malignant tumor of nipple and areola, ductal tumor

+∞

6.2

L01XE33

ATC

[U] palbociclib

+∞

6.2

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

6.2

9706

FHL

Ablation mammae, includes axillary exploration

+∞

6.2

8090/3-C44.7

ICD-O-3

Basal cell carcinoma, NOS, of skin of lower limb and hip

+∞

6.2

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

+∞

6.2

C76.2

ICD-10 Finland

Malignant neoplasm of other and ill-defined sites: Abdomen

+∞

6.2

C73.90

ICD-10 Finland

Malignant tumor of the thyroid gland (thyroid gland) without histology

+∞

6.2

L01EX03

ATC

pazopanib; oral

+∞

6.2

C53.1

ICD-10 Finland

Malignant neoplasm: Exocervix

+∞

6.2

9861/3-C42.1

ICD-O-3

Acute myeloid leukemia, NOS, of bone marrow

+∞

6.2

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

+∞

6.2

C53.90

ICD-10 Finland

Malignant tumor in unspecified localization in cervix uteri without histology

+∞

6.2

C50.93

ICD-10 Finland

Malignant tumor in other specified localization in mammary gland other or unspecified histology

+∞

6.2

C26.9

ICD-10 Finland

Malignant neoplasm: Ill-defined sites within the digestive system

+∞

6.2

8890/3-C55.9

ICD-O-3

Leiomyosarcoma, NOS, of uterus, NOS

+∞

6.2

L02BA02

ATC

toremifene; oral

+∞

6.2

C80.0

ICD-10 Finland

Malignant neoplasm, primary site unknown, so stated

+∞

6.2

WC401

NOMESCO Finland

Simple antibody therapy of local recurrence of tumour

+∞

6.2

8010/3-C54.9

ICD-O-3

Carcinoma, NOS, of corpus uteri

+∞

6.2

C50.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of breast

+∞

6.2

8480/3-C18.1

ICD-O-3

Mucinous adenocarcinoma of appendix

+∞

6.2

8070/3-C34.1

ICD-O-3

Squamous cell carcinoma, NOS, of upper lobe, lung

+∞

6.2

PJD55

NOMESCO Finland

Block dissection of inguinal lymph nodes

+∞

6.2

8480/3-C54.1

ICD-O-3

Mucinous adenocarcinoma of endometrium

+∞

6.2

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

6.2

JBA10

NOMESCO Finland

Transabdominal biopsy or excision of lesion of diaphragm

+∞

6.2

C79.6

ICD-10 Finland

Secondary malignant neoplasm of ovary

+∞

6.2

C18.0

ICD-10 Finland

Malignant neoplasm: Caecum

+∞

6.2

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

6.2

C53.10

ICD-10 Finland

Malignant tumor of the exocervix without histology

+∞

6.2

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

+∞

6.2

C34.82

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary adenocarcinoma

+∞

6.2

C50.30

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, no histological veryfication

+∞

6.2

1742A

ICD-9 Finland

Malignant neoplasm of female breast, Upper-inner quadrant

+∞

6.2

C03.1

ICD-10 Finland

Malignant neoplasm: Lower gum

+∞

6.2

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

+∞

6.2

8930/3-C54.2

ICD-O-3

Endometrial stromal sarcoma, NOS, of myometrium

+∞

6.2

XX3AT

NOMESCO Finland

Other labeling with ultrasound guidance

26.7

6.2

Z80.9

ICD-10 Finland

Family history of malignant neoplasm, unspecified

26.7

6.2

JGB07

NOMESCO Finland

Laparoscopic partial proctectomy with total excision of mesorectum

26.7

6.2

JGB04

NOMESCO Finland

Laparoscopic partial proctectomy with partial excision of mesorectum

26.7

6.2

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

0.7

6.2

252

3442

65000

ICD-8 Finland

Delivery without mention of complication, Occipital presentation

0.8

6.2

1166

13204

R4110

NOMESCO Finland

Physiotherapy

1.2

6.2

868

7391

A10AE04

ATC

insulin glargine; parenteral

1.4

6.2

278

2040

WPA15

NOMESCO Finland

Palliative care consultation with the patient and loved ones

6.3

6.2

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

1.7

6.1

573

R03BA02

ATC

budesonide; inhalant

0.8

6.1

419

5294

5702

FHL

Local lymph node removal (eg armpit, groin)

12.5

6.1

R01AD58

ATC

fluticasone, combinations; nasal

0.8

6.1

488

6041

N95

ICD-10 Finland

Menopausal and other perimenopausal disorders

0.5

6.1

869

ZXC15

NOMESCO Finland

Use of photodynamic technique

2.6

6.0

122

QB2S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in chest

8.6

6.0

C01DA14

ATC

isosorbide mononitrate; oral

0.8

6.0

381

4869

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.7

6.0

331

4314

WPA44, ,

SPAT

6.7

6.0

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.2

6.0

659

5462

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.6

6.0

140

901

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.1

6.0

241

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2686

14703

3.69

312.80

3.0

2.4

—

estimate

—

(4035726) Immunohistochemistry procedure

1102

909

16.53

307.65

1.6

1.2

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

790

779

12.48

307.65

1.4

187.23

78.56

pmol/l

5.41

780

755

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1955

1825

20.57

307.65

5.0

1.5

44.32

24.81

u/ml

1.90

1926

1731

(4281824) Cell count and differential, peritoneal fluid

989

222

59.44

307.65

1.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

253

174

15.48

285.44

1.0

1.3

—

(40768795) Lymph node Pathology biopsy report

162

31.85

249.12

1.1

1.0

—

(40768804) Tissue Pathology biopsy report

2213

11888

3.01

242.57

2.7

1.7

—

(3044640) Blood type and Crossmatch panel - Blood

1976

10113

2.94

234.54

2.4

2.1

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

675

2030

3.81

192.05

3.3

1.4

9.33

2.69

ug/l

1.41

537

1520

(3024561) Albumin [Mass/volume] in Serum or Plasma

2595

16642

2.69

179.36

4.7

3.7

34.81

35.72

g/l

12.92

2471

15193

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

134

18.23

166.11

2.3

1.1

26.23

15.18

u/ml

3.03

124

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1483

7663

2.51

156.48

2.4

2.0

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

735

2765

3.05

143.23

1.7

2.0

0.22

0.20

g/l

8.94

707

2512

(3002256) Pathology report gross observation

699

2633

3.02

135.33

1.4

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1301

6790

2.38

129.36

1.4

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2527

17568

2.26

122.41

7.3

3.6

10.34

10.72

umol/l

0.79

2417

16319

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1093

5443

2.40

119.33

3.9

2.2

0.79

0.82

mmol/l

9.52

1033

4937

(3002173) Hemoglobin [Mass/volume] in Arterial blood

732

3107

2.67

111.47

4.9

6.7

118.49

118.94

g/l

0.27

717

3026

(3003396) Base excess in Arterial blood by calculation

837

3816

2.52

109.80

4.8

6.1

1.12

1.45

mmol/l

1.73

685

3151

(3003694) ABO and Rh group [Type] in Blood

1351

7657

2.17

105.90

1.4

1.3

—

(3019977) pH of Arterial blood

833

3856

2.48

105.31

4.9

6.1

7.41

7.42

6.38

502

2228

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

829

3849

2.47

103.99

4.9

6.1

5.28

5.08

kpa

7.97

801

3682

(3027801) Oxygen [Partial pressure] in Arterial blood

826

3846

2.46

102.85

4.9

6.1

13.76

11.67

kpa

19.88

798

3675

(3023368) Bacteria identified in Blood by Culture

1491

8996

2.07

97.24

4.4

3.8

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

2528

18427

2.07

96.85

12.1

6.5

4.07

4.19

e9/l

1.51

2186

15545

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

18.44

95.09

3.4

1.0

84.80

32.88

u/ml

0.77

(3016502) Oxygen saturation in Arterial blood

704

3373

2.33

80.32

4.8

6.4

96.98

95.26

22.14

683

3240

(3008152) Bicarbonate [Moles/volume] in Arterial blood

517

2193

2.57

76.91

5.7

6.1

25.09

24.91

mmol/l

0.58

500

2097

(3019060) Gas panel - Arterial blood

492

2102

2.54

71.85

3.4

4.4

—

(3014007) Fractional oxyhemoglobin in Arterial blood

466

2012

2.50

66.29

5.4

7.6

94.97

93.53

10.66

466

2005

(3015377) Calcium [Moles/volume] in Serum or Plasma

1887

13493

1.78

65.00

3.8

2.2

2.37

mmol/l

0.50

1723

11771

(40768793) Breast Pathology biopsy report

152

333

4.71

64.54

1.3

1.2

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

28.98

64.19

1.6

1.0

8.86

1.60

ug/l

—

(3032080) INR in Blood by Coagulation assay

2229

16784

1.77

63.62

14.6

16.6

1.21

1.28

inr

7.49

1870

13871

(3033658) Prothrombin time (PT) actual/Normal

1271

8132

1.84

63.24

3.7

3.4

94.36

91.34

4.23

1244

7925

(3013826) Glucose [Moles/volume] in Serum or Plasma

2640

21004

1.80

61.13

5.0

4.3

6.91

6.70

mmol/l

5.65

2554

19826

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2258

17623

1.67

51.39

5.9

5.2

1.20

1.22

mmol/l

23.14

2086

15842

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3148

26968

1.89

51.00

9.2

5.8

86.16

77.21

u/l

11.61

3001

24980

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2474

19820

1.68

50.51

6.6

5.7

1.21

1.23

mmol/l

27.38

2093

16878

(3031040) Bacteria [#/volume] in Urine by Automated count

2939

24891

1.75

46.52

6.5

5.8

4383.77

3865.42

e6/l

0.12

332

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

+∞

45.92

1.1

0.0

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

566

3076

1.98

44.58

4.2

2.1

252.00

237.68

u/l

1.61

536

2846

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

186

628

3.06

42.14

1.5

2.2

4.24

3.54

g/l

5.84

180

595

(1617658) Protocol used for examination of sentinel lymph nodes

+∞

41.73

1.1

0.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

14.93

41.66

1.1

—

(3000991) Gas panel - Venous blood

517

2788

1.99

41.45

5.4

6.6

—

(3026008) Bacteria identified in Urine by Culture

1929

15050

1.56

39.29

4.4

3.8

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

527

2960

1.90

37.22

4.9

5.6

1.22

1.35

mmol/l

2.02

519

2901

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

203

777

2.70

36.50

2.8

1.8

149.21

17.01

u/ml

1.72

164

617

(3009261) Glucose [Presence] in Urine by Test strip

2447

20381

1.54

35.28

5.2

4.8

0.04

0.01

estimate

0.70

527

3931

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

583

3530

1.77

31.93

3.8

3.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

217

935

2.40

30.45

2.7

3.1

0.36

0.39

iu/ml

0.67

122

553

(3020779) Urea [Moles/volume] in Serum or Plasma

470

2714

1.83

30.06

6.1

5.8

9.84

10.45

mmol/l

0.88

448

2549

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

179

720

2.56

29.11

1.5

1.9

97.91

94.78

1.04

174

682

(3042936) Bacteria identified in Isolate by Culture

684

4436

1.66

28.87

2.2

1.9

—

(3002582) Erythrocytes [#/volume] in Urine

1506

11698

1.47

27.96

3.6

3.4

52.12

67.50

e6/l

0.47

1151

8794

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

172

698

2.53

27.47

1.5

2.2

233.95

192.18

6.25

166

656

(40758558) Short blood count panel - Blood

1351

10307

1.48

27.33

8.5

4.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

257

1244

2.14

27.28

2.1

1.7

3.83

2.04

ug/l

0.78

221

1056

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

128

449

2.91

27.13

2.5

2.0

233.07

23.81

u/ml

0.78

114

401

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

464

2806

1.74

25.16

1.6

—

(3018418) pH of Serum or Plasma

1525

12136

1.42

23.69

3.8

3.3

7.40

1.39

1085

8594

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

142

570

2.55

23.22

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1363

10670

1.43

23.03

4.2

2.6

32.41

30.84

u/l

0.63

1295

9858

(3036489) Thrombin time

219

1064

2.12

23.01

1.5

1.7

20.58

21.03

0.50

202

929

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

7.67

22.93

2.3

1.2

159.90

72.93

ng/l

—

(3030467) Casts [#/volume] in Urine by Automated count

1308

10170

1.43

22.93

3.3

0.54

0.47

e6/l

0.40

952

7412

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

6.15

22.81

2.9

2.6

2.38

0.69

4.30

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

708

4889

1.55

22.42

8.0

7.1

—

(3018095) Leukocytes [#/volume] in Urine

1659

13530

1.39

21.79

4.6

4.1

189.86

142.39

e6/l

0.72

1183

9160

(36304419) Bacteria [Presence] in Urine

1235

9574

1.43

21.73

3.3

3.2

0.00

245.68

estimate

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

653

4484

1.55

21.09

4.7

4.3

1.04

mmol/l

0.26

597

4012

(3017181) Myelocytes/Leukocytes in Blood

460

2935

1.64

20.21

3.5

3.8

1.27

0.66

3.55

162

583

(3029937) Albumin [Presence] in Urine by Test strip

1415

11375

1.38

19.66

5.7

4.9

0.00

estimate

0.99

494

3689

(3007853) Bacteria identified in Skin by Aerobe culture

580

3947

1.55

19.38

1.8

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

46.23

19.18

6.0

1.4

0.00

—

estimate

—

(3000850) Epithelial cells [#/volume] in Urine

1058

8152

1.41

18.70

2.9

2.8

7.79

7.40

e6/l

0.36

956

7369

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

433

2784

1.62

18.37

3.7

2.4

59.71

60.89

ml/min/173m2

0.31

190

1183

(3020630) Protein [Mass/volume] in Serum or Plasma

470

3105

1.58

17.79

3.6

1.5

65.97

66.36

g/l

0.56

427

2743

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

295

1738

1.75

17.36

6.2

7.7

15.78

15.72

0.16

284

1665

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1103

8652

1.38

17.28

3.1

2.4

2.49

2.47

mmol/l

10.53

1012

7646

(3018677) aPTT in Platelet poor plasma by Coagulation assay

706

5123

1.46

17.13

1.9

28.95

29.30

0.69

686

4947

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3538

33519

1.63

16.32

21.0

15.5

31.10

21.95

mg/l

35.74

3126

27306

(3035637) Corticotropin [Mass/volume] in Plasma

329

2.68

16.14

1.8

1.4

23.77

27.47

ng/l

0.38

329

(3002179) Metamyelocytes/Leukocytes in Blood

427

2820

1.58

16.12

3.4

3.6

0.89

0.54

2.41

137

575

(3021601) Nitrite [Presence] in Urine by Test strip

2269

19973

1.33

16.00

5.3

4.7

0.00

estimate

0.65

519

3897

(3049717) Cytology report of Urine Cyto stain

166

835

2.03

15.94

2.4

1.8

—

(3021440) Promyelocytes/Leukocytes in Blood

430

2852

1.57

15.93

3.6

3.8

0.23

0.05

3.82

132

505

(3044889) 12 lead EKG panel

2747

24900

1.35

15.67

4.8

4.3

0.29

0.46

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1414

11702

1.33

15.15

3.2

2.4

55.38

59.41

u/l

1.53

1295

10596

(3039000) Anion gap in Blood by calculation

144

701

2.09

15.11

3.8

6.4

10.89

11.21

mmol/l

0.57

134

624

(3018572) Chloride [Moles/volume] in Blood

144

701

2.09

15.11

3.8

6.4

105.63

104.03

mmol/l

4.47

134

624

(40760892) CBC W Ordered Manual Differential panel - Blood

898

6959

1.38

14.76

4.9

4.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

5.98

14.31

5.8

1.3

51.21

84.03

ug/l

0.39

(3026782) Osmolality of Urine

886

6882

1.37

14.29

3.1

3.0

482.12

486.73

mosm/kgh2o

0.29

767

5931

(3009214) Lutropin [Units/volume] in Serum or Plasma

193

3.09

14.28

1.3

1.2

26.65

21.41

u/l

1.16

147

(3035350) Ketones [Presence] in Urine by Test strip

2281

20262

1.31

14.18

5.4

4.7

0.00

2.52

estimate

2.01

551

4128

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

272

1663

1.68

13.99

3.8

4.4

1.67

1.54

1.25

258

1580

(3021589) Normoblasts [#/volume] in Blood

1755

15081

1.30

13.91

14.0

10.4

0.00

e9/l

0.99

1441

12253

(40761536) Microorganisms panel - Urine sediment

399

2693

1.54

13.61

5.6

4.5

—

(3015736) pH of Urine

1860

16154

1.29

13.40

4.7

4.2

6.39

6.33

1.28

1033

8629

(3027945) Reticulocytes/Erythrocytes in Blood

545

3940

1.45

13.22

2.8

2.0

1.94

1.84

1.14

478

3411

(3025159) Blasts/Leukocytes in Blood

420

2900

1.50

12.86

3.7

4.0

0.09

0.02

1.32

118

492

(3007930) Methemoglobin/Hemoglobin.total in Blood

247

1526

1.66

12.22

3.9

4.6

0.87

0.02

233

1445

(3006315) Basophils [#/volume] in Blood

1971

17364

1.27

12.20

6.0

5.7

0.04

e9/l

5.21

1651

14659

(3004789) Transferrin [Mass/volume] in Serum or Plasma

726

5588

1.37

12.17

2.4

2.5

2.29

2.38

g/l

3.16

652

5023

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

674

5128

1.38

12.14

2.4

2.5

19.30

20.20

1.09

608

4616

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

442

3119

1.47

12.12

3.5

3.0

1.24

mmol/l

0.33

382

2526

(3001604) Monocytes [#/volume] in Blood

1961

17287

1.27

11.99

6.0

5.7

0.56

0.57

e9/l

0.75

1643

14593

(3019198) Lymphocytes [#/volume] in Blood

2001

17700

1.27

11.82

6.1

5.7

1.73

1.86

e9/l

2.70

1708

15294

(40768806) Pleura Pathology biopsy report

188

2.90

11.79

1.4

1.5

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

505

3688

1.42

11.51

3.2

3.3

5.74

5.85

kpa

1.74

488

3610

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

725

5624

1.36

11.50

3.2

3.0

5.24

5.19

e6/l

0.02

336

2604

(3002030) Lymphocytes/Leukocytes in Blood

1821

15997

1.26

11.13

6.0

5.9

25.38

28.00

17.22

1712

14917

(3022948) Iron [Moles/volume] in Serum or Plasma

771

6067

1.34

11.08

2.4

2.5

11.16

12.00

umol/l

2.66

703

5497

(3019069) Monocytes/Leukocytes in Blood

1791

15714

1.26

11.02

6.0

8.78

8.76

0.09

1664

14471

(3013115) Eosinophils [#/volume] in Blood

2009

17863

1.26

11.02

6.2

5.8

0.17

0.19

e9/l

9.30

1705

15337

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

270

1765

1.57

10.61

1.5

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

981

8035

1.30

10.49

1.6

1.7

1.92

1.22

mg/l

4.09

794

6252

(3004809) Band form neutrophils/Leukocytes in Blood

377

2.23

10.48

2.1

2.3

2.00

1.02

1.26

325

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

810

6468

1.32

10.44

3.0

2.9

1.64

1.44

e6/l

0.52

422

3456

(3024354) Oxygen [Partial pressure] in Venous blood

438

3184

1.42

10.21

2.8

4.43

4.39

kpa

0.18

424

3113

(3047181) Lactate [Moles/volume] in Blood

176

1045

1.72

10.14

3.9

5.5

1.23

1.30

mmol/l

0.49

162

924

(3006504) Eosinophils/Leukocytes in Blood

1777

15689

1.24

9.98

5.9

2.60

2.90

7.63

1656

14450

(3042111) Morphology [Interpretation] in Bone marrow Narrative

280

2.38

9.79

1.5

1.1

—

(3025130) Human papilloma virus identified in Specimen

101

510

2.01

9.73

1.4

1.7

—

(3002032) Base excess in Venous blood by calculation

482

3592

1.39

9.72

3.2

3.3

2.15

2.10

mmol/l

0.09

418

3213

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

290

1966

1.51

9.67

3.6

3.7

49.05

46.87

0.77

284

1944

(3011397) Hemoglobin [Presence] in Urine by Test strip

1170

9898

1.26

9.45

4.8

4.6

0.30

0.19

—

133

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1699

14987

1.24

9.42

5.6

4.8

0.05

0.88

estimate

1.90

388

3067

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

139

788

1.79

9.42

1.8

1.7

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

402

2929

1.42

9.23

2.8

2.4

0.52

0.50

e6/l

0.06

386

2774

(3018010) Neutrophils/Leukocytes in Blood

1768

15711

1.23

9.00

6.0

5.8

59.17

57.25

7.76

1685

14804

(40757494) Bilirubin.total [Moles/volume] in Blood

160

2.77

8.95

1.9

18.76

14.81

umol/l

—

(42870588) Differential panel, method unspecified - Blood

1327

11448

1.24

8.89

5.6

5.5

—

(3022096) Basophils/Leukocytes in Blood

1767

15724

1.23

8.80

6.0

0.65

0.70

2.83

1644

14466

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2264

20692

1.23

8.60

3.6

3.1

54.00

42.19

u/l

5.08

2092

18906

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

757

6139

1.29

8.51

1.8

1.9

—

(3023520) Reticulocytes [#/volume] in Blood

413

3066

1.39

8.49

3.1

2.0

74.10

70.42

e9/l

1.00

295

2266

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

374

2735

1.41

8.40

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

3.63

8.27

1.8

1.1

4.27

2.32

ug/l

0.21

(3045142) Bone marrow Pathology biopsy report

129

2.89

8.16

1.2

1.1

—

(3012544) pH of Venous blood

483

3700

1.35

8.15

3.2

3.3

7.39

7.38

1.28

285

2067

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1493

13148

1.22

7.99

3.1

3.2

1633.43

1369.98

ng/l

0.98

1299

11370

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

487

3755

1.34

7.86

2.7

2.0

9.59

6.32

umol/l

1.81

414

3188

(3014051) Protein [Presence] in Urine by Test strip

1219

10534

1.23

7.80

3.6

3.5

0.15

0.07

0.52

375

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

271

2.23

7.78

2.6

1.8

1129.42

3285.39

u/l

0.60

127

(3023199) Leukocytes [#/volume] in Pleural fluid

288

2.17

7.52

1.3

1.4

1233.64

1747.01

e6/l

0.42

207

(3019550) Sodium [Moles/volume] in Serum or Plasma

3622

35174

1.45

7.49

26.4

19.2

139.45

139.78

mmol/l

11.49

3577

34389

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

219

2.35

7.45

1.7

1.6

—

(3003434) Protein [Mass/volume] in Pleural fluid

310

2.12

7.39

1.3

1.4

34.27

27.94

g/l

3.57

268

(40758358) Immune stain study

+∞

7.29

1.0

0.0

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

552

4381

1.30

7.24

1.7

1.8

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

248

2.24

7.19

1.3

1.5

42903.77

56207.67

e6/l

0.17

129

(1616796) Gas panel - Central venous blood

117

685

1.73

7.19

3.2

3.5

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

438

3377

1.33

7.06

3.3

1.8

423.46

377.23

nmol/l

4.64

407

3042

(3023103) Potassium [Moles/volume] in Serum or Plasma

3622

35221

1.43

6.96

26.4

19.4

3.96

mmol/l

0.03

3575

34372

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

258

1842

1.43

6.66

6.8

7.3

24.61

24.68

mmol/l

0.12

250

1791

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1142

9931

1.21

6.65

2.4

2.5

3.15

2.88

mg/l

2.91

976

8582

(3027273) Bicarbonate [Moles/volume] in Venous blood

247

1760

1.43

6.45

3.0

25.45

25.60

mmol/l

0.27

241

1711

(3009343) pH of Capillary blood

285

2086

1.40

6.40

4.0

3.4

7.41

7.42

2.06

238

1705

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

292

2150

1.39

6.33

4.1

3.4

5.26

5.25

kpa

0.08

278

2028

(3026726) Creatinine [Moles/volume] in Specimen

11.03

6.29

1.1

4.2

1610.09

377.60

umol/l

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

591

7177

0.79

6.25

1.3

11.26

14.57

u/ml

0.61

228

2639

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

+∞

6.25

1.0

0.0

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1654

14962

1.18

6.09

4.2

38.23

83.77

ng/l

1.52

1291

10915

(3008757) Leukocyte morphology finding [Identifier] in Blood

236

2.13

5.91

2.3

2.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

574

4694

1.26

5.89

1.7

1.8

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1415

15637

0.85

5.44

2.0

1.44

1.31

mmol/l

8.49

1124

12838

(3022145) Colonoscopy Study observation

475

3845

1.27

5.30

1.3

—

(1175426) CD3 cells/Lymphocytes in Blood

120

2.51

5.19

2.0

1.6

67.90

73.04

0.88

114

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

642

7568

0.82

5.04

1.3

46.75

35.17

iu/ml

0.80

202

2472

(3045788) Cell count panel - Pleural fluid

238

2.03

5.04

1.3

1.5

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

3.41

5.02

2.3

1.8

43.42

47.86

0.48

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

241

1799

1.36

4.85

4.0

3.3

1.88

2.39

mmol/l

0.96

178

1382

(3000012) Reticulocyte production index

451

1.72

4.85

2.0

1.7

0.88

0.89

0.05

267

(3037756) Immunofixation for Serum or Plasma

113

730

1.56

4.84

1.5

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

180

1285

1.42

4.73

1.3

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

258

1.95

4.72

1.4

1.3

42.44

42.46

u/l

0.00

188

(21494755) Public health laboratory ask at order entry panel

1456

0.63

4.69

1.3

1.4

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

3.03

4.66

1.2

2.5

965.80

727.67

e6/l

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

404

1.75

4.66

3.7

3.4

222.78

470.53

iu/ml

—

(3019150) Specific gravity of Urine by Refractometry

1052

9332

1.17

4.61

5.7

5.1

1.02

1.34

kg/l

0.80

746

6127

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

141

968

1.47

4.57

2.3

3.0

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

154

2.22

4.52

4.8

1.1

84.65

142.81

u/ml

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

3353

32529

1.23

4.49

22.2

15.0

73.18

73.55

ml/min/173m2

0.53

3197

30028

(40765096) Chromosome analysis panel by Banding

4.83

4.49

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

256

1.93

4.48

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3248

33419

0.83

4.41

5.2

5.5

1.54

1.60

mmol/l

15.08

2901

30472

(3037522) Nuclear Ab [Titer] in Serum

435

5269

0.80

4.40

1.3

1.4

536.09

585.73

titre

0.25

1306

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

155

1095

1.43

4.35

1.4

1.5

—

(3012441) Differential panel - Pleural fluid

224

1.98

4.34

1.3

1.5

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

132

907

1.47

4.28

2.7

2.2

124.50

126.55

g/l

0.47

101

698

(3040151) Glucose [Moles/volume] in Capillary blood

407

1.71

4.28

4.3

6.7

7.51

7.22

mmol/l

0.25

333

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

261

2016

1.32

4.21

3.2

3.3

24.62

24.58

mmol/l

0.06

256

1995

(3041096) Erythrocytes [Presence] in Urine by Automated

1118

10029

1.16

4.18

5.0

4.1

0.01

0.56

estimate

2.21

390

3075

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

295

2325

1.29

4.11

1.7

1.8

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

4.01

4.09

1.3

21.18

1.97

ug/l

—

(21494814) CD8 cells/Lymphocytes in Specimen

2.87

4.06

2.3

1.7

29.89

24.78

0.80

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

111

2.35

3.99

1.9

1.6

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

311

2483

1.27

3.92

4.1

3.0

4.49

4.41

pmol/l

0.41

284

2152

(3012501) Base excess in Blood by calculation

642

1.52

3.81

3.1

3.5

2.71

2.85

mmol/l

0.20

452

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1733

16106

1.14

3.80

2.9

3.1

149.40

101.92

ug/l

11.66

1561

14732

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3281

33650

0.84

3.75

5.3

5.6

4.75

4.77

mmol/l

0.60

2950

30915

(3001019) Free T4 and TSH panel - Serum or Plasma

1200

0.65

3.55

1.7

1.8

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

501

1.57

3.53

1.3

1.4

—

(3023420) DNA double strand Ab [Units/volume] in Serum

121

1690

0.71

3.50

1.7

1.8

7.12

7.88

iu/ml

0.12

403

(21494434) Karyotype in Bone marrow

145

2.08

3.47

1.2

1.1

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

171

1281

1.35

3.46

1.9

2.0

715.91

750.55

ug/l

0.04

165

1204

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

252

3158

0.78

3.45

1.5

—

(3044007) Cell count panel - Peritoneal fluid

2.77

3.41

1.2

2.4

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

116

816

1.43

3.41

2.6

2.5

1.73

1.71

mg/l

0.07

704

(3017143) Hepatitis C virus Ab [Presence] in Serum

300

2433

1.25

3.35

1.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

263

1.76

3.26

2.4

2.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

162

1217

1.35

3.24

1.9

1.8

—

(3044242) Glucose [Moles/volume] in Arterial blood

170

1.95

3.23

3.2

1.9

8.60

8.58

mmol/l

0.01

170

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

3.34

3.22

1.1

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

407

3425

1.21

3.21

2.5

5.37

6.13

ug/l

0.29

342

2875

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

502

0.49

3.20

1.1

1.2

0.54

0.59

ratio

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

173

1316

1.33

3.18

2.1

1.5

39.76

30.71

mg/l

1.08

142

1093

(3034860) Kappa light chains.free [Mass/volume] in Serum

173

1320

1.33

3.12

2.1

1.5

35.33

39.01

mg/l

0.93

143

1103

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

105

743

1.42

3.02

1.9

1.5

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

10.01

2.98

1.2

58.80

387.40

umol/l

—

(42529406) Shigella sp [Presence] in Stool by Culture

142

1061

1.35

2.97

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

532

1.49

2.94

2.2

2.5

34.28

31.51

umol/l

0.36

470

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3635

35781

1.25

2.92

30.2

20.8

74.19

72.46

umol/l

2.77

3599

35224

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

200

1573

1.29

2.91

1.9

1.6

1.75

1.66

g/l

0.47

155

1352

(3014765) Yersinia sp identified in Stool by Organism specific culture

141

1056

1.35

2.91

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

394

4625

0.84

2.91

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

642

1.44

2.87

1.3

1.6

—

(3026493) Urate [Moles/volume] in Serum or Plasma

965

8767

1.13

2.86

2.7

2.2

340.42

329.97

umol/l

2.10

807

7422

(3019832) Treponema pallidum Ab [Presence] in Serum

1001

0.66

2.85

1.2

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

169

1304

1.31

2.85

2.0

1.9

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

139

1044

1.34

2.82

1.2

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

255

2074

1.25

2.82

2.6

2.5

1.16

1.14

0.22

255

2066

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

2795

26995

1.13

2.80

27.2

18.9

14.13

13.68

44.63

2764

26545

(3000492) Spirometry study

238

2926

0.80

2.80

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

138

1037

1.34

2.80

4.5

5.2

—

(40768441) Liver Pathology biopsy report

151

1.93

2.79

1.1

1.4

—

(3017354) Segmented neutrophils/Leukocytes in Blood

269

1.68

2.78

2.3

2.2

64.12

60.35

0.56

227

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

117

2.06

2.76

1.3

1.7

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

8.34

2.75

1.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3589

35303

1.22

2.74

15.4

11.3

23.72

22.69

u/l

3.22

3485

33829

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

100

717

1.41

2.71

1.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

573

0.57

2.67

1.1

1.2

1.60

1.63

g/l

0.28

573

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

151

1160

1.31

2.65

2.0

1.5

1.49

1.50

ratio

0.02

694

(3020682) Albumin/Creatinine [Ratio] in Urine

1436

13406

1.11

2.64

4.1

3.9

7.10

7.08

mg/mmol

0.01

849

7460

(3051387) C reactive protein [Mass/volume] in Capillary blood

107

783

1.38

2.59

3.7

3.9

27.38

24.19

mg/l

0.42

558

(3012516) Albumin [Mass/volume] in Urine

1412

13186

1.11

2.56

3.4

3.3

34.58

31.96

mg/l

0.26

858

7479

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

5.46

2.54

1.0

1.5

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3367

34297

0.86

2.52

6.2

6.6

2.72

mmol/l

0.01

3025

31450

(3021879) Hepatitis B virus core Ab [Presence] in Serum

191

1525

1.27

2.51

1.3

—

(3022313) Gas panel - Capillary blood

179

1418

1.27

2.51

4.1

3.4

—

(3009508) Creatinine [Moles/volume] in Urine

1435

13429

1.11

2.48

3.3

3.2

6.17

6.03

mmol/l

0.70

1181

11114

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

232

1.69

2.48

1.3

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

232

1.69

2.48

1.3

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

232

1.69

2.48

1.3

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

102

748

1.37

2.45

1.8

2.4

76.32

64.74

ug/min

0.17

416

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

455

1.48

2.45

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

327

1.57

2.43

1.2

107.39

108.51

pmol/l

0.07

327

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

548

1.43

2.41

1.4

1.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

524

1.44

2.39

1.1

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

410

1.50

2.36

1.2

1.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

103

765

1.36

2.31

2.0

1.7

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

546

1.42

2.28

1.4

1.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

126

1620

0.77

2.21

1.3

1.11

0.90

u/ml

0.09

143

(3042517) Benzodiazepines panel - Urine

5.56

2.21

1.8

1.1

—

(3023410) Appearance of Cerebral spinal fluid

311

0.48

2.20

1.7

1.5

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

2.69

2.20

1.1

1.6

35.25

21.48

g/l

2.32

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

791

8655

0.89

2.20

1.3

1.12

1.58

u/ml

1.16

215

2223

(3008898) HLA-B27 [Presence]

958

0.70

2.19

1.0

1.1

—

(3042631) Mycobacterium sp identified in Specimen

361

1.50

2.17

1.7

3.4

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

181

1.72

2.14

1.5

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

182

0.38

2.14

1.3

1.6

1430.87

1035.97

mu/l

—

144

(3010503) CD19 cells [#/volume] in Blood

102

1.97

2.10

2.9

2.0

102.65

219.06

e6/l

0.52

(40768443) Skin Pathology biopsy report

192

1572

1.23

2.07

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

643

1.36

2.05

1.4

1.3

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

433

1.44

2.02

1.4

1.3

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3128

31932

0.89

2.02

4.3

4.6

1.36

1.27

mmol/l

12.45

2757

28651

(3035933) Granulocytes/Leukocytes in Blood

621

1.36

1.98

2.8

3.0

60.33

58.20

0.83

621

(3037121) Protein [Mass/volume] in Urine

143

1141

1.26

1.96

3.3

2.5

289.08

400.88

mg/l

0.53

306

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

4.55

1.94

1.6

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

302

3494

0.85

1.93

2.7

3.2

179.50

203.32

ng/l

0.63

274

3204

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

565

1.37

1.92

1.4

1.2

0.20

0.19

nmol/l

0.17

435

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3257

33152

0.89

1.91

7.6

7.1

41.03

39.80

mmol/mol

12.25

2998

30550

(3035947) Staphylolysin Ab [Units/volume] in Serum

135

1.78

1.91

1.1

—

2.80

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

376

3298

1.16

1.89

2.3

2.2

43.77

45.16

u/l

0.04

311

2745

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

381

1.45

1.89

1.1

1.2

287.23

286.22

u/ml

0.01

224

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

212

1.61

1.88

1.2

1.1

20.36

20.22

u/l

0.01

179

(3003888) Timothy IgE Ab [Units/volume] in Serum

369

0.57

1.87

1.1

1.47

1.60

u/ml

—

174

(36660697) Celiac disease serology panel - Serum

269

3130

0.85

1.85

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

401

1.43

1.82

1.1

1.56

660.54

iu/ml

—

(3008037) Lactate [Moles/volume] in Venous blood

124

983

1.27

1.81

3.2

3.1

1.60

1.56

mmol/l

0.23

124

961

(3010370) Gastrin [Moles/volume] in Serum or Plasma

2.57

1.80

1.8

1.6

46.08

41.23

pmol/l

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

206

2445

0.83

1.79

2.5

17.28

27.40

au/ml

1.75

207

(3010726) Horse dander IgE Ab [Units/volume] in Serum

312

0.54

1.77

1.1

1.80

0.96

u/ml

—

159

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1202

0.77

1.76

1.4

1.3

1.94

6.31

u/ml

—

135

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

216

1.58

1.76

1.2

1.1

77.47

73.00

u/l

0.20

182

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

455

1.39

1.75

1.2

66.60

21.64

u/l

0.44

387

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

460

0.63

1.75

1.2

1.1

0.74

1.07

u/ml

0.29

256

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

297

0.54

1.74

1.0

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

360

0.58

1.73

1.1

0.62

0.83

u/ml

—

147

(3017732) Neutrophils [#/volume] in Blood

490

4405

1.13

1.73

3.8

2.8

5.70

4.40

e9/l

0.91

412

3673

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.67

1.72

1.1

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

1.70

0.0

1.2

—

66.85

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

357

1.43

1.69

1.2

1.3

192.50

157.53

au/ml

—

112

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

190

2256

0.83

1.68

2.0

3.28

3.22

ratio

0.29

150

1776

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1002

0.75

1.68

1.5

1.7

5.68

4.22

mg/l

0.56

765

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

409

1.40

1.66

1.2

60.14

58.21

u/l

0.16

350

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1202

0.78

1.66

1.5

1.3

20.53

5.35

u/ml

0.57

209

(40762365) Oxygen content in Arterial blood by calculation

2.80

1.65

1.6

2.9

15.27

14.53

ml/dl

—

(3050794) Legionella sp Ab [Presence] in Serum

2.80

1.65

1.1

1.0

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

1.98

1.64

1.3

1.5

67.86

119.39

ug/l

—

(4094501) Cardiovascular stress test using bicycle ergometer

975

0.75

1.63

1.1

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

3.57

1.61

1.2

1.0

32.92

23.46

u/l

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1238

0.79

1.58

1.6

1.7

—

(4212803) Bone marrow aspirate examination

3.00

1.58

1.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

741

0.72

1.57

1.4

15.44

25.39

e6/l

0.40

558

(3035715) Granulocytes [#/volume] in Blood

534

1.34

1.56

2.8

3.1

4.54

4.05

e9/l

0.48

534

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.28

1.55

1.7

2.5

4.70

5.00

ug/l

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.03

1.54

1.2

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

551

0.69

1.52

1.3

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

190

2231

0.84

1.51

1.3

42.58

50.88

au/ml

0.29

151

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

442

4887

0.89

1.49

5.1

5.5

33.08

34.08

1.04

252

3034

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

136

1121

1.22

1.46

4.0

3.6

24.64

25.43

mmol/l

1.85

122

990

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

163

1.60

1.46

1.3

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

163

1.60

1.46

1.3

1.2

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

292

0.58

1.45

3.6

3.5

13.12

13.39

0.53

287

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

752

0.74

1.44

1.4

500.57

1332.77

e6/l

1.49

603

(3021788) Differential panel - Synovial fluid

786

0.75

1.44

1.6

1.5

—

1.00

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.13

1.44

1.2

1.0

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

174

1475

1.19

1.40

1.3

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

721

1.27

1.40

1.4

1.3

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

390

1.36

1.37

1.5

1.4

27240.00

182180.38

e6/l

2.83

252

(3050129) First trimester maternal screen panel - Serum or Plasma

120

0.42

1.37

1.2

1.5

—

(3022475) Manganese [Moles/volume] in Blood

2.94

1.36

1.2

1.0

0.18

0.15

umol/l

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.94

1.36

1.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

298

1.41

1.35

1.2

1.1

—

(1002224) Polysomnography panel

1145

0.80

1.35

1.1

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

138

1646

0.83

1.33

1.8

3.50

3.51

mmol/l

0.05

103

1163

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

944

0.78

1.33

1.5

1.2

46.91

52.81

u/ml

0.13

118

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

951

8961

1.08

1.31

1.8

33729060.32

37006584.30

pmol/l

0.06

759

7188

(3010813) Leukocytes [#/volume] in Blood

3641

36081

1.15

1.28

34.8

23.7

6.74

6.59

e9/l

3.89

3565

34945

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

161

1886

0.85

1.28

1.0

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

123

1021

1.21

1.27

3.7

3.2

2.08

1.29

index

0.88

475

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

108

1311

0.82

1.27

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

140

1177

1.20

1.27

1.2

—

(3007461) Platelets [#/volume] in Blood

3640

36073

1.15

1.27

34.8

23.7

260.39

257.27

e9/l

1.95

3571

35116

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

466

1.31

1.26

1.2

—

(3035941) MCH [Entitic mass]

3640

36076

1.14

1.25

34.6

23.6

30.08

30.20

4.07

3605

35545

(3024731) MCV [Entitic mean volume] in Red Blood Cells

3640

36076

1.14

1.25

34.7

23.6

91.40

0.02

3606

35546

(3004588) Protein electrophoresis panel - Serum or Plasma

303

2707

1.13

1.24

1.9

1.5

—

(3026361) Erythrocytes [#/volume] in Blood

3640

36078

1.14

1.24

34.7

23.7

4.25

4.37

e12/l

39.37

3560

34938

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

3640

36078

1.14

1.24

35.1

24.0

38.22

39.56

11.29

3606

35534

(3005988) Vibrio sp identified in Specimen by Organism specific culture

469

1.31

1.21

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

3640

36083

1.14

1.21

35.1

23.9

126.69

131.30

g/l

76.30

3609

35559

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

885

0.79

1.20

1.4

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

462

1.30

1.19

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.77

1.16

1.1

—

(44806420) Estimation of glomerular filtration rate

342

1.35

1.16

2.5

2.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

386

1.33

1.14

1.2

1.1

—

0.34

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

257

2881

0.88

1.14

1.2

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

352

1.34

1.13

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

647

6921

0.92

1.13

1.4

2.56

2.42

g/l

0.51

356

3706

(3028026) IgM [Mass/volume] in Serum or Plasma

207

1819

1.15

1.11

1.7

1.5

1.10

1.24

g/l

1.25

190

1643

(3051611) Lipemic interference index of Serum or Plasma

362

1.33

1.11

3.2

3.3

13.25

13.74

index

0.09

141

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

159

1838

0.86

1.10

1.2

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

136

0.51

1.09

1.0

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

139

1187

1.18

1.09

1.8

1.9

132.19

9.08

iu/l

0.47

462

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.38

1.09

1.4

1.3

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

219

0.59

1.09

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

363

0.69

1.08

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

164

0.55

1.08

1.1

1.2

127.56

144.69

mmol/24h

—

164

(3017569) Oxygen content in Arterial blood

194

1.45

1.06

3.2

2.1

15.75

15.82

0.03

194

(3000093) Morphology [Interpretation] in Blood Narrative

254

1.38

1.04

1.1

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

544

1.25

1.03

1.3

1.2

—

nmol/l

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

276

0.65

1.03

1.1

2.45

3.33

u/ml

—

126

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1839

18938

0.94

1.02

2.6

2.5

80.24

81.51

nmol/l

1.20

1640

16702

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

171

1.46

1.02

1.4

1.3

—

(44790049) Parainfluenza type 3 nucleic acid detection

359

1.31

1.02

1.4

1.2

—

(44790048) Parainfluenza type 2 nucleic acid detection

359

1.31

1.02

1.4

1.2

—

(44806118) Parainfluenza type 4 nucleic acid detection

359

1.31

1.02

1.4

1.2

—

(44790047) Parainfluenza type 1 nucleic acid detection

359

1.31

1.02

1.4

1.2

—

(4146454) Self-monitoring of blood glucose

439

1.28

1.01

2.6

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

262

0.65

1.00

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.00

1.00

1.1

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

170

1488

1.15

0.99

1.5

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

352

1.31

0.99

1.2

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

285

0.66

0.99

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

158

0.57

0.98

1.1

1.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

175

0.57

0.98

1.0

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1078

0.83

0.98

1.5

0.00

2.39

iu/ml

0.54

213

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

218

2441

0.89

0.98

1.5

1.43

1.41

0.35

189

2086

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.97

0.0

1.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

560

0.77

0.97

1.1

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

1.63

0.97

2.5

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

199

1.41

0.95

1.2

1.6

16.90

9.27

umol/l

0.46

137

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

149

1.48

0.95

1.5

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

321

2930

1.10

0.95

1.4

1.5

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3288

33245

0.93

0.94

6.7

6.5

2.08

1.99

mu/l

1.69

2996

30566

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

401

1.28

0.91

1.1

131.10

120.71

1.04

355

(3047189) Immunofixation for 24 hour Urine

102

1.57

0.90

1.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.07

0.89

10.8

13.8

3.90

4.38

mmol/l

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

245

1.35

0.88

1.2

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

493

1.24

0.88

1.2

—

(3025941) Bacteria identified in Stool by Culture

208

1863

1.12

0.88

1.3

—

(3045424) Erythrocytes [Presence] in Urine

213

1911

1.12

0.88

2.4

2.1

0.00

estimate

0.50

603

(4268621) Lupus anticoagulant assay

298

1.31

0.87

2.1

2.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

705

1.20

0.85

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

705

1.20

0.85

1.2

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.67

0.85

2.3

2.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

811

0.82

0.84

1.1

2.80

3.59

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

297

0.71

0.83

1.1

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

400

0.75

0.83

1.1

1.2

—

76.65

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

130

1486

0.87

0.83

1.6

23.15

19.86

u/ml

0.16

267

(3018333) Ribosomal P Ab [Presence] in Serum

285

0.70

0.83

1.1

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

571

1.21

0.82

1.3

249.81

223.82

miu/ml

0.18

246

(3019309) Folate [Moles/volume] in Red Blood Cells

750

7880

0.94

0.82

1.8

1289.98

1193.77

nmol/l

1.71

559

5847

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

720

0.82

0.81

1.1

1.2

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

318

0.72

0.81

1.1

1.2

—

(3011985) Renin [Units/volume] in Plasma

581

1.21

0.81

1.2

1.3

43.47

54.22

mu/l

0.35

519

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

155

1.42

0.81

1.5

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

427

1.24

0.80

1.2

4.29

4.10

u/ml

0.03

143

(3047007) Chlamydophila sp Ab [Presence] in Serum

431

0.76

0.80

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

509

1.22

0.80

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

500

1.22

0.80

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

356

1.27

0.79

2.7

2.4

2.93

2.15

u/field

0.38

184

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

2.72

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.82

0.79

3.0

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

139

1.44

0.79

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

139

1.44

0.79

1.5

—

(3017704) Immunofixation for Urine

190

1.37

0.78

1.6

1.3

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

1.67

0.78

1.0

1.1

—

80.78

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.67

0.78

1.0

1.1

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

131

1.45

0.78

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

131

1.45

0.78

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

131

1.45

0.78

1.2

—

(4034850) Laboratory test

139

1226

1.14

0.77

13.5

10.6

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

338

0.74

0.77

3.6

—

(3038515) Glucose [Moles/volume] in Venous blood

843

1.17

0.77

3.4

3.2

7.97

7.72

mmol/l

0.38

823

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

349

0.74

0.77

1.7

1.6

97.97

92.87

ng/l

0.15

349

(3021960) Folate [Moles/volume] in Serum or Plasma

1275

12327

1.05

0.77

1.7

21.48

21.73

nmol/l

0.20

1082

10132

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.76

0.0

2.1

—

1.65

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

0.00

0.76

0.0

1.0

—

0.01

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

132

1.44

0.75

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

256

0.70

0.75

1.1

2.32

2.59

u/ml

—

109

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

302

0.73

0.75

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

313

0.73

0.75

1.1

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

437

0.78

0.74

1.1

1.62

3.21

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.57

0.74

1.3

1.6

1.16

1.18

mmol/l

0.28

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

1.67

0.74

1.1

138.78

115.28

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

301

0.73

0.74

1.1

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

278

0.72

0.74

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

734

7691

0.94

0.74

4.1

4.3

142.11

264.71

ng/l

1.66

590

6268

(3044290) Cell count panel - Cerebral spinal fluid

689

0.82

0.73

1.2

1.4

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

139

1232

1.13

0.73

3.7

3.6

0.77

0.83

nmol/l

0.99

114

1021

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

228

1.32

0.72

1.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

288

0.73

0.72

1.0

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1096

0.86

0.72

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

124

1094

1.14

0.71

1.6

1.4

0.00

g/l

-0.00

100

950

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.92

0.70

1.6

2.8

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

309

0.74

0.70

1.0

1.1

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

297

0.74

0.69

1.0

1.1

—

68.92

—

(3034426) Prothrombin time (PT)

1.51

0.69

1.1

1.2

29.00

28.65

0.10

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

391

3663

1.07

0.68

3.3

3.1

91.65

84.86

ng/l

0.78

317

3020

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.56

0.68

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.53

0.68

1.2

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

341

0.76

0.68

1.2

1.1

—

(3020491) Glucose [Moles/volume] in Blood

222

1.31

0.68

2.0

2.3

7.65

7.04

mmol/l

0.43

142

(3000570) Elastase.pancreatic [Mass/mass] in Stool

139

1240

1.13

0.68

1.5

1.4

256.53

289.22

ug/g

0.95

737

(3048689) Calprotectin [Mass/mass] in Stool

447

4742

0.94

0.67

2.0

2.1

143.28

134.40

ug/g

0.16

340

3663

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

507

0.81

0.67

1.1

3.97

25.23

au/ml

—

(3011436) Histone Ab [Units/volume] in Serum

0.54

0.66

1.0

1.1

—

(3002619) Bacteria identified in Specimen by Culture

0.53

0.66

1.0

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.79

0.66

1.0

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

440

1.21

0.65

1.8

387.27

347.42

mu/l

0.35

388

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

304

1.25

0.65

1.1

1.0

—

(3005322) IgE [Units/volume] in Serum or Plasma

201

2196

0.91

0.64

1.3

194.80

171.93

u/ml

0.14

187

2017

(3048929) Epstein Barr virus Ab [Presence] in Serum

562

1.18

0.62

1.2

—

(3016038) Potassium [Moles/volume] in Urine

333

1.23

0.62

1.0

1.1

32.61

32.71

mmol/l

0.01

269

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.63

0.62

1.0

1.1

11.63

37.94

iu/ml

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

100

880

1.14

0.62

2.1

11.87

mg/l

0.00

815

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

1.60

0.61

1.0

1.1

—

79.44

—

(3045414) Leukocytes [Presence] in Urine

440

4161

1.06

0.60

2.3

2.2

0.01

estimate

0.05

742

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.60

0.0

1.4

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

345

0.78

0.60

1.1

—

1.03

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

427

1.20

0.59

1.1

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

519

0.83

0.58

1.4

1.6

62.73

57.65

0.47

311

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

149

1.34

0.57

1.3

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

149

1.34

0.57

2.8

4.7

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

184

0.71

0.56

1.2

1.1

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

115

1.39

0.56

2.3

3.0

4.96

5.31

kpa

0.71

115

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

115

1.39

0.56

2.3

3.0

9.71

9.90

kpa

0.17

115

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

172

0.70

0.56

1.1

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3349

33731

0.95

0.55

6.0

5.8

6.20

5.95

mmol/l

19.51

2991

30553

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

709

0.86

0.55

1.6

1.3

568.57

383.38

titre

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

222

1.26

0.53

1.3

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

114

1024

1.12

0.53

1.6

1.5

0.00

g/l

-0.00

100

948

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

160

1.31

0.53

1.0

1.1

1.08

1.06

ratio

0.32

129

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

196

1.28

0.52

2.0

2.3

2.95

3.04

u/field

0.02

121

(3005719) IgG [Mass/volume] in Serum or Plasma

248

2315

1.08

0.52

2.7

2.6

9.98

10.46

g/l

1.28

226

2114

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

152

1.32

0.52

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

132

0.68

0.51

3.4

2.9

37.27

21.38

mu/l

—

125

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

100

1.40

0.51

1.1

1.5

3.28

2.34

umol/l

0.48

(4024509) Urine culture

218

2341

0.93

0.50

2.0

2.1

—

(4195642) Thrombophilia screening test

398

1.18

0.50

1.1

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

156

0.70

0.49

1.3

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

109

0.64

0.48

2.6

1.7

13.36

9.56

ug/l

—

109

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

189

0.74

0.48

1.9

104.06

52.46

ug/l

0.59

184

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

172

1.28

0.48

1.4

1.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

118

1071

1.10

0.47

1.5

1.6

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

708

0.87

0.47

1.6

1.3

—

90.77

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1097

0.90

0.46

1.5

1.8

0.26

0.23

g/l

2.08

1037

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1832

18631

0.97

0.46

2.3

96.47

99.48

pmol/l

1.74

941

8593

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

496

1.15

0.45

1.7

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

363

0.83

0.45

1.1

2.88

4.02

eliau/ml

—

125

(3024869) Neuronal Ab [Presence] in Serum

1.40

0.45

1.3

1.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

201

1.25

0.44

1.4

1.3

0.19

0.31

nmol/l

1.27

140

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

123

1124

1.10

0.44

1.6

1.5

0.01

g/l

0.05

103

1004

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

253

0.79

0.44

1.2

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

152

0.72

0.44

2.3

1.1

40.02

40.04

g/l

0.00

152

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.61

0.43

1.0

1.2

—

(3019174) dRVVT (LA screen)

1.61

0.43

1.0

1.3

—

(3006462) Nitrate [Presence] in Urine

185

0.76

0.43

4.9

4.1

—

(3003181) Sodium [Moles/volume] in Urine

104

945

1.10

0.42

1.3

1.4

56.98

59.53

mmol/l

0.28

763

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.43

0.42

1.4

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

218

0.78

0.42

1.1

1.0

0.09

10.00

nmol/l

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

273

0.80

0.42

1.1

1.3

0.09

1.20

u/ml

—

160

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

122

1.31

0.42

1.6

1.5

34.69

30.37

umol/l

0.82

113

(3022621) pH of Urine by Test strip

312

3284

0.95

0.42

3.2

3.3

6.00

6.08

0.94

220

2284

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.40

0.42

1.6

1.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

267

1.20

0.42

1.3

1.2

—

(3004451) EKG impression Narrative

249

1.21

0.41

1.2

1.4

—

(3030313) Adrenal Ab [Titer] in Serum

0.00

0.41

0.0

1.1

—

14.20

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.41

0.0

1.3

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

0.07

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.41

0.0

3.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

426

1.15

0.41

1.2

2.62

4.06

u/ml

0.92

173

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

0.07

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

1.47

0.40

1.6

1.4

1.00

2.63

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

250

1.20

0.40

1.3

1.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.40

0.0

1.7

—

567.58

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.0

—

0.89

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

151

1.26

0.38

1.0

4.6

82.93

63.08

mg/l

0.31

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.39

0.38

1.2

1.1

0.03

u/ml

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.32

0.37

1.9

2.0

—

(3024932) HLA-DR beta [Type]

1.35

0.37

1.2

1.0

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.30

0.37

1.9

2.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

116

1.29

0.37

1.1

1.0

93.44

95.16

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

881

0.91

0.36

1.4

0.22

0.32

mg/l

0.86

307

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.27

0.36

1.3

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

413

1.14

0.35

1.0

1.1

—

(3014891) Appearance of Pleural fluid

1.40

0.35

1.2

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

255

0.82

0.35

1.1

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

273

1.17

0.35

1.3

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

264

1.18

0.34

1.3

1.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

223

2351

0.95

0.34

2.4

2.5

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

321

1.15

0.33

1.2

1.5

7.12

6.75

g/l

0.22

226

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.67

0.32

1.0

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

209

0.81

0.32

1.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

209

0.81

0.32

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

147

1380

1.07

0.31

1.7

1.5

0.42

0.33

g/l

0.25

113

1154

(1761868) Lipid panel - Serum or Plasma

1117

10961

1.03

0.31

3.8

3.6

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

103

1110

0.93

0.31

1.5

1.7

1.29

1.20

g/l

2.05

1046

(3006922) Hepatitis E virus Ab [Presence] in Serum

193

1.19

0.30

1.1

—

(4015189) Microbial culture of sputum

0.71

0.30

1.6

2.7

—

(3033099) Centromere Ab [Titer] in Serum

0.71

0.30

1.1

1.2

—

(4198724) Urine methamphetamine measurement

1.30

0.30

1.0

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.30

0.30

3.3

3.4

0.43

0.81

u/field

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

400

1.13

0.30

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

535

0.90

0.29

1.3

—

(3024263) Appearance of Synovial fluid

176

1.19

0.28

1.4

1.6

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

162

0.80

0.28

3.2

1.6

222.57

129.87

umol/l

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

251

1.16

0.28

1.3

—

(3020650) Glucose [Presence] in Urine

103

1.26

0.28

1.5

1.9

0.00

0.03

estimate

0.50

103

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

183

0.82

0.27

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

362

3499

1.04

0.27

1.6

—

(3020876) Protein [Mass/time] in 24 hour Urine

347

1.13

0.26

1.9

1.8

1.02

0.91

g/24h

0.15

170

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

101

944

1.07

0.26

1.5

1.6

—

(3028433) Virus identified in Specimen by Culture

1.26

0.26

1.2

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.68

0.26

1.0

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

694

1.08

0.25

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

821

1.07

0.24

1.8

1.9

4.45

4.85

mmol/24h

0.47

707

(3035320) C reactive protein [Mass/volume] in Body fluid

264

1.14

0.24

2.5

2.8

33.92

27.29

mg/l

0.27

186

(3024139) IgG subclass 3 [Mass/volume] in Serum

321

1.12

0.24

1.2

1.5

0.50

0.38

g/l

0.47

227

(3028192) IgG subclass 2 [Mass/volume] in Serum

321

1.12

0.24

1.2

1.5

2.80

2.70

g/l

0.11

223

(3006270) Folate [Moles/volume] in Blood

350

0.88

0.24

1.0

1.2

342.04

357.07

nmol/l

0.17

276

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

137

0.80

0.24

1.0

1.1

1410.00

1713.00

miu/ml

0.39

137

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

149

1417

1.05

0.23

1.5

1.4

9.94

9.86

g/l

0.07

126

1203

(3024471) HLA-A [Type]

1.28

0.23

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

125

1.20

0.22

1.1

—

88.33

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.19

0.21

1.2

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

5.0

—

320.70

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

0.21

0.0

1.1

—

(3006567) Chloride [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.0

—

(3033926) Protein [Mass/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

3.0

—

1.37

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.21

0.0

1.6

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

2717

27013

1.02

0.21

30.2

20.8

328.53

329.81

g/l

12.29

2694

26870

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.16

0.21

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.00

—

(3028707) Methadone [Presence] in Urine by Screen method

164

1.16

0.20

1.3

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.20

0.0

1.4

—

246.79

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1.25

0.20

1.0

1.5

43.00

72.65

nmol/l

—

(3002523) Influenza virus A Ag [Presence] in Specimen

323

0.90

0.19

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

323

0.90

0.19

1.1

—

(3011288) Drugs identified in Urine by Screen method Nominal

212

1.13

0.19

1.5

1.6

—

(3008295) Osmolality of Serum or Plasma

447

0.92

0.19

1.2

1.4

275.18

271.88

mosm/kgh2o

0.32

328

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.13

0.18

3.2

2.3

0.76

2.45

ratio

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

157

1510

1.04

0.18

1.6

1.4

3.18

2.92

g/l

1.90

136

1314

(3044927) Protein electrophoresis panel - Urine

445

1.08

0.17

1.3

1.2

—

(3044941) Cell count panel - Synovial fluid

732

0.94

0.17

1.8

1.4

—

(3007916) DNA double strand Ab [Titer] in Serum

0.75

0.17

1.0

1.3

—

126.98

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

0.73

0.17

1.2

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

173

0.87

0.16

1.6

1.9

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

524

1.07

0.16

2.1

27.78

26.77

mg/l

0.05

164

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

111

1.17

0.15

1.2

1.4

27.43

32.40

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.14

0.15

1.3

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

1.14

0.15

8.7

6.1

8.84

8.19

mmol/l

—

(3026389) Candida sp identified in Specimen by Organism specific culture

667

0.94

0.15

1.5

1.4

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

2739

27275

1.01

0.14

4.5

4.9

18.15

13.80

mm/h

29.47

2506

25270

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

0.81

0.14

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.80

0.14

1.3

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

0.80

0.14

1.0

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.78

0.14

1.0

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

346

0.92

0.13

1.3

1.7

—

(3013637) Mi-2 Ab [Presence] in Serum

117

0.85

0.13

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

117

0.85

0.13

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

117

0.85

0.13

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

117

0.85

0.13

1.0

1.1

—

(40768797) Stomach Pathology biopsy report

536

5438

0.98

0.13

1.3

1.2

—

(3027944) Amphetamines [Presence] in Urine

316

1.08

0.12

1.3

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.18

0.12

1.3

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.18

0.12

1.3

1.1

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

166

1616

1.03

0.11

1.6

1.4

3.86

3.64

g/l

1.20

145

1424

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

166

1616

1.03

0.11

1.6

1.4

4.44

4.29

g/l

0.72

145

1423

(4211845) Urine protein measurement

199

0.90

0.11

4.2

3.9

—

(3028300) Cannabinoids [Presence] in Urine

318

1.07

0.11

1.3

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

504

1.05

0.11

1.2

1.6

0.57

0.69

g/l

0.62

379

(3019225) pH of Specimen

401

3950

1.02

0.11

4.5

3.8

7.36

7.37

0.30

283

2501

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

150

1461

1.03

0.10

2.2

2.0

36.92

40.30

u/l

1.33

135

1280

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

239

0.92

0.10

1.4

1.5

7.88

8.29

u/l

0.05

188

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

146

0.89

0.10

1.0

1.6

250.85

205.88

u/l

0.69

146

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

177

0.90

0.10

1.0

—

(3000764) Benzodiazepines [Presence] in Urine

319

1.07

0.10

1.3

1.2

—

(3024928) Oxygen saturation in Venous blood

889

1.04

0.10

2.3

2.6

54.60

60.18

1.58

861

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

166

1621

1.03

0.10

1.6

1.4

7.95

7.64

g/l

1.23

145

1426

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.11

0.09

1.2

1.0

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.11

0.09

1.0

1.2

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.06

0.09

1.0

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.15

0.09

1.3

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

339

0.94

0.08

3.8

2.8

43.97

17.78

mg/l

0.46

230

(3000330) Specific gravity of Urine by Test strip

218

2219

0.98

0.08

4.0

3.9

1.02

ratio

0.53

194

2005

(3025018) Bordetella pertussis Ab [Titer] in Serum

204

1.08

0.08

1.1

1.3

—

(44813793) Dust mix specific IgE antibody measurement

257

0.93

0.08

1.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.78

0.08

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.08

0.08

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.87

0.07

1.0

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.82

0.07

1.0

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

122

0.90

0.07

1.1

—

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

0.89

0.06

1.3

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

173

0.92

0.06

2.9

1.8

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

0.84

0.06

1.0

1.1

—

(3016879) Cocaine [Presence] in Urine

295

1.05

0.06

1.3

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

142

0.92

0.06

1.1

1.2

—

12.00

—

(37208534) Antinuclear antibody arbitrary concentration in serum

105

0.86

0.06

1.1

—

(3027008) Opiates [Presence] in Urine

315

1.05

0.06

1.3

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

158

1.08

0.06

1.4

1.2

147.18

133.03

nmol/l

0.55

158

(3020911) Cortisol [Moles/time] in 24 hour Urine

121

0.91

0.06

1.2

1.5

67.18

61.41

nmol/24h

0.14

121

(21494890) Protein electrophoresis panel - 24 hour Urine

286

1.05

0.06

1.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2930

29346

0.99

0.06

5.5

5.1

15.21

15.07

pmol/l

2.25

2665

26712

(3007566) Smooth muscle Ab [Titer] in Serum

940

1.02

0.05

1.1

1.2

75.00

171.11

titre

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.11

0.05

1.3

1.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

198

1.06

0.05

1.5

1.9

72.67

78.27

umol/l

0.59

198

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

161

0.93

0.05

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

169

1.07

0.05

2.4

2.0

511.00

344.91

mu/l

0.43

129

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

101

1.09

0.04

1.2

1.1

—

(3022689) Creatine [Moles/volume] in Urine

119

0.92

0.04

1.5

1.3

6.95

6.39

mmol/l

0.15

119

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

129

0.93

0.03

1.0

1.1

18.20

223.28

ng/l

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

159

0.94

0.03

1.1

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

598

1.02

0.03

1.3

1.6

0.93

0.77

nmol/l

0.93

492

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

128

0.94

0.02

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

253

2514

1.01

0.02

1.3

1.2

111.42

137.97

u/ml

0.72

108

972

(3023511) Choriogonadotropin [Units/volume] in Urine

148

0.95

0.02

1.2

—

(3000494) Fungus identified in Specimen by Culture

425

4233

1.00

0.02

1.4

—

(3014271) Vancomycin [Susceptibility]

228

0.96

0.02

2.6

3.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

820

0.99

0.02

1.4

1.3

42.39

38.84

iu/l

0.39

728

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1289

12909

1.00

0.02

2.4

2.2

199.30

196.89

u/l

0.02

1218

12041

(3023419) Bacteria identified in Sputum by Culture

428

0.98

0.01

2.8

2.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

106

1067

0.99

0.01

1.7

1.6

15518.46

12866.01

e6/l

0.19

741

(3004775) Volume in Urine collected for unspecified duration

234

1.03

0.00

1.8

2.4

719.31

638.44

0.56

168

(4062490) Immunoglobulin typing, IgG

314

1.02

0.00

1.2

1.5

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

116

1.03

0.00

1.1

1.3

73.83

133.61

nmol/l

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

163

0.98

0.00

1.0

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

206

1.02

0.00

2.2

2.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

1.03

0.00

1.0

1.1

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

106

1.04

0.00

8.8

12.9

0.70

0.66

mmol/l

0.19

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

149

1.01

0.00

1.0

1.1

1.12

1.16

u/l

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

234

0.98

0.00

1.0

1.1

6.70

11.33

iu/ml

—

(3003329) Lymphocytes/Leukocytes in Synovial fluid

363

0.99

0.00

1.4

1.5

28.72

35.66

0.60

213

(4133840) Spirometry

0.98

0.00

1.2

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

0.97

0.00

1.7

1.4

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

4.0

—

(3033086) Enterovirus Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

1.40

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

2.80

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

0.92

-0.00

1.3

1.2

13.88

12.61

mm/h

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

-0.00

0.0

2.0

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.2

—

2.05

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

-0.00

0.0

1.2

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

-0.00

0.0

1.0

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

24.04

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.03

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.00

-0.00

3.0

2.3

0.67

0.62

mmol/l

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

-0.00

0.0

2.0

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(40768446) Kidney Pathology biopsy report

1.01

-0.00

1.3

1.5

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

141.83

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

-0.00

0.0

1.3

—

2.07

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

28.30

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

2915.14

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

1106.25

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_CORPUS_UTERI_WIDE – Malignant neoplasm of corpus uteri, including Hilmo

GWS hits: 2

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of corpus uteri, including Hilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of corpus uteri, including Hilmo (C3_CORPUS_UTERI_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints